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Resumo 
A quinoxalina e seus derivativos são uma importante classe de compostos 
heterocíclicos, onde os elementos N, S e O substituem átomos de carbono no anel. A 
fórmula molecular da quinoxalina é C8H6N2, formada por dois anéis aromáticos, benzeno e 
pirazina. É rara em estado natural, mas a sua síntese é de fácil execução. Modificações na 
estrutura da quinoxalina proporcionam uma grande variedade de compostos e actividades, tais 
como actividades antimicrobiana, antiparasitária, antidiabética, antiproliferativa, anti-
inflamatória, anticancerígena, antiglaucoma, antidepressiva apresentando antagonismo do 
receptor AMPA. Estes compostos também são importantes no campo industrial devido, por 
exemplo, ao seu poder na inibição da corrosão do metal. 
A química computacional, ramo natural da química teórica é um método bem 
desenvolvido, utilizado para representar estruturas moleculares, simulando o seu 
comportamento com as equações da física quântica e clássica. Existe no mercado uma grande 
variedade de ferramentas informaticas utilizadas na química computacional, que permitem o 
cálculo de energias, geometrias, frequências vibracionais, estados de transição, vias de reação, 
estados excitados e uma variedade de propriedades baseadas em várias funções de onda não 
correlacionadas e correlacionadas. Nesta medida, a sua aplicação ao estudo das quinoxalinas é 
importante para a determinação das suas características químicas, permitindo uma análise mais 
completa, em menos tempo, e com menos custos. 
Palavras-chave: Quinoxalina, derivativos, actividade biológica, indústria, química 
computacional. 
 
 
Abstract 
Quinoxaline derivatives are an important class of heterocycles compounds, where N, S 
and O elements replace some carbon atoms in the ring. Quinoxaline molecular formula is 
C8H6N2, formed by two aromatic rings, benzene and pyrazine. It is rare in natural state, but 
their synthesis is easy to perform. Modifying its structure is possible to obtain a wide variety 
of compounds and activities such as antimicrobial, antitubercular, antiviral, antifungal, 
antiamoebic, antimalarial and leishmanial, antidiabetic, antiproliferative, anti-inflamatory, 
anticancer, antiglaucoma, antidepressant presenting AMPA receptor antagonism. These 
 VI 
compounds are also important in industrial field due to, for example, its power in metal 
corrosion inhibition.  
Computational chemistry, natural branch of theorical chemistry, is a method well 
developed, used to represent molecular structures, simulating their behavior with quantic and 
classic physics equations. There are several softwares on the market, that allows the 
calculation of energies, geometries, vibrational frequencies, transition states, pathways of 
reaction, excited states properties and a variety of functions based on various uncorrelated and 
correlated waves. Its application to the study of quinoxalines is important for the determination 
of their chemical properties, enabling a more complete analysis in less time with lower costs. 
Keywords: Quinoxaline, derivatives, biological activity, industry, computational 
chemistry. 
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1.Introduction 
 The present study emerges in the following of the investigations carried out by the 
Center for Health and Environmental Research, in the School of Allied Health Sciences. In 
such studies, the researchers synthezised the quinoxalines derivatives under study, and 
evaluated their antimicrobial activity. The group also evaluated the toxicity and 
antitumoral activity in cell lines, such as human gingival fibroblasts, human MG-63 
osteoblast-like cells, murine skin melanoma B16-F10, murine brain BC3H1 cells and 
human colorectal adenocarcinoma HT29. Those studies showed some very promising 
results. The main aim of this work is to determine the quinoxaline derivatives chemical 
properties and reactivity. These results will then help to understand if the antimicrobial 
activity and toxicity are related or not with chemical features of the compounds.  
This introduction will provide a review regarding chemical properties of quinoxaline 
compound and its derivatives. 
 
1.1.Quinoxaline and its derivatives features 
Quinoxaline derivatives are an important class of heterocycles compounds, in which 
N, S and O elements replace one or more carbon atoms of the ring[1], and the approved 
number for the quinoxaline ring system is shown in Figure 1, where 2 and 3 are designated 
α-positions[2]. They are important in industry due to their power to inhibit the metal 
corrosion[3-5], in the prepare of the porphyrins since their structure is similar to the 
chromophores in the natural system, and their utility in the electroluminescent materials[6-
8], and are even more significant in pharmacological industry since they show wide 
biological properties[1, 9-12] such as antibacterial, antifungal, anticancer, antitubercular, 
antileishmanial, antimalarial, antidepressant, antimycobacterial and anticandida, and 
neurological activities, among others. All this activities are possible due to the quinoxaline 
structure once its nucleus, in numerous cases, act as a precursor to assembly a large number 
of quinoxaline derivatives, which consequently, provide a large number of new compounds 
with biological and therapeutic applications[1]. 
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Figure 1: Quinoxaline compound: a) Lewis structure; b) non-optimized 3D structure. 
Particularly, quinoxaline is formed by two aromatic rings, benzene and pyrazine, 
reason why it is also called benzopyrazine, and is described as a bioisoster of quinoline, 
naphatelene and benzothiophene[13]. The atoms S and N play an important role in the ring 
since they stabilize ion radical species and extended π-conjugation facilitate in decreasing 
columbic repulsion. Molecular weight of the quinoxaline is 130.1466400, with a molecular 
formula of C8H6N2, and it is a white crystalline powder[1].  
Chemically, quinoxaline is a low melting solid, purified by destilation, and a fraction 
of boiling point (b.p.) 108º-111º/12mm has a melting point (m.p.) 29-30ºC[2, 13]. 
Quinoxalines are soluble in water, and produce monoquaternary salts when treated with 
quaternizing agents, like methyl sulfate and methyl p-toluenesulfate. The quaternary salts 
of 2-alkylquinoxalines are unstable and can be converted into complex colored products 
when under oxidation[2]. It is weakly basic with a pKa of 0,60 in water at 20ºC, and 
nitration occurs only under forcing conditions (Concentrated Nitric Acid (HNO3), Oleum, 
90ºC), resulting the formation of two compounds: 5-nitroquinoxaline (1,5%) and 5,7-
dinitro-quinoxaline (24%)[13]. Its second pKa is -5,52, meaning that quinoxaline is 
significantly diprotonated only in a strongly acidic medium[2]. 
Quinoxaline has a dipole moment of 0,51 D in benzene ring, and its first and second 
ionization potentials, measured by photon electron spectroscopy, are 8,99 and 10,72 eV, 
respectively[2]. However it is not known certainly from which orbital the first electron is 
lost, since highest-occupied π-orbital and non-bonding orbitals are very close in energy. 
The heat of atomization was calculated to be 79,739 eV by a self-consistent field molecular 
orbital treatment[2]. Molecular orbital calculations of the π-electron density were made, 
and showed that the highest electron density at the ring carbon is at positions 5 and 8, 
followed by positions 6 and 7, and the lowest at 2 and 3 positions[2]. 
a) b) 
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Table 1: Quinoxaline properties. 
Quinoxaline Properties 
Formula C8H6N2 
Molecular Weight 130.1466400 
Acidity (pKa) 0,56 
Second pKa -5,52 
Melting Temperature 29-30ºC 
Natural State 
White crystaline 
powder 
Dipole Moment 0,51 D 
Ionization (1
st
/2
nd
) 8,99/10,72 eV 
Atomization Heat 70,739eV 
 
Quinoxaline compounds are rare in natural state, being the most of them, of synthetic 
origin. There are different ways to sinthezised quinoxalines. One of the method used to 
synthesized quinoxalines is to condense o-disubstituted benzene with a two carbon 
synthon. Therefore, the condensation of o-phenylenediamine with α-dicarbonyl compounds 
result in quinoxaline formation (Figure 2)[2]. 
  
 
Figure 2: Quinoxaline synthesis. 
Quinoxaline and their derivatives could be converted in both mono and di-N-oxides 
by oxidation with peracids[2]. 
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2.Quinoxaline Activities 
Quinoxalines are compounds with a vast fiel of applications, including medical field 
with their biological activities, and in industry, where quinoxalines are used, for example, 
to reduce maintenance costs, and as host compounds in phosphorescent organic light-
emitting diode (PHOLEDs). 
2.1.Biological Activity 
The study of quinoxaline and its derivatives has become a subject of interest in recent 
years on account of their wide variety in biological activity and also their therapeutic 
applications, such as antimicrobial agents, since some antibiotics have quinoxaline 
compound in their structure (echinomycin), as well as some recognized drugs like 
Brimonidins which alleviates glaucoma symptoms[1]. Although rare in nature, synthesized 
quinoxaline and derivatives are included in various antibiotics such as echinomycin, 
levomycin and actinomycin, which are known to inhibit the growth of Gram-positive 
bacteria and also active against transplant tumors[13, 14]. 
The vast scope of synthesized quinoxaline and derivatives potentials is well 
referenced and published in a wide range of scientific journals. We analyze in detail, 
transversally and in context the relevant scientific data pertaining great potentials of 
quinoxaline and derivatives in literature. 
 
2.1.1.Antimicrobial Activity 
The antimicrobial resistance is a serious threat to global public health, mainly result 
of the widely disseminated and careless use of antimicrobials, and demands a continuous 
effort in order to seek for better antimicrobial agents effective against resistant pathogenic 
microorganisms[13, 15-17]. There are a wide range of quinoxaline derivatives with 
antimicrobial activity documented, of which we present a relevant survey in the following 
paragraphs. 
2.1.1.1.Antibacterial Activity 
A new series of 8-chloro-1,4-substituted(1,2,4)triazolo(4,3a) quinoxaline derivatives 
(Figure 3) was synthesized and screened for antimicrobial and antioxidant activities[18]. 
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The antibacterial activity was screened against Gram-positive Staphylococcus aureus and 
Bacillus subtilis, and Gram-negative Proteus vulgaris and Klebsiella pneumonia, using 
chloramphenicol as reference drugs[16].  
 
 
Figure 3: 8-chloro-1,4-disubstituted (1,2,4)triazolo(4,3a) quinoxaline derivatives core : a) Lewis structure; b) 
non-optimized 3D structure. 
Ammar et al[19], have synthesized thieno(2,3-d)pyrimidines and pyrrolo(3,4-
b)quinoxalines which antibacterial activity was tested against S. aureus and Escherichia 
coli.  
 
2.1.1.2.Antitubercular Activity 
Tuberculosis (TB) is a contagious disease, caused by the infection of Mycobacterium 
tuberculosis, which have a high rate of mortality in the world. About 3 million people die 
every year from TB, and 8 million new cases are estimated each year, which 95% of them 
occur in developing countries[20-22]. 
The therapy used in these days to fight TB consists in the administration of one of 
three drugs (isoniazid, rifampin or pyrazinamide) for 2 months, followed by 4 months of 
follow-up therapy with isoniazid and rifampin. However, due to the arising of TB 
multidrug resistant (MDR) it is required the development of new therapeutic agents, with a 
unique mechanism of action, able to treat MDR forms of the disease. 
Several studies have been described, concerning synthesis and biological activity of a 
large amount of quinoxalines and 1,4-di-N-oxide quinoxaline derivatives, where 
compounds such as 7-chloro-3-(p-substituted)phenylaminoquinoxaline-2-carbonitrile-1,4-
di-N-oxide, 6,7-dichloro-2-ethoxycarbonyl-3-methylquinoxaline-1,4-di-N-oxide and 3-
a) b) 
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acetamide-6,7-dichloroquinoxaline-2-carbonitrile-1,4-di-N-oxide derivatives have been 
shown to possess M. tuberculosis growth inhibition values from 99 to 100%[16, 23]. 
However, it is observed that the lack of the two N-oxide groups lead to the loss of the 
antimycobacterial activity [23-25]. 
Some novel condensed bridgehead nitrogen heterocycles of quinoxalines has been 
synthesized and showed activity against M. tuberculosis H37Rv species [13, 16, 26]. The 
compound 3-methyl-2-phenylthioquinoxaline-1,4-dioxide generally showed a good activity 
against M. tuberculosis in the preliminary in vitro evaluation and exhibited Minimum 
Inhibitory Concentration (MIC) between 0.39 and 0.78µg mL
−1
(rifampicin MIC=0.25µg 
mL
−1
)[9]. The MIC is defined as the lowest concentration of an antimicrobial that will 
inhibit the visible growth of a microorganism after overnight incubation. The range of 
antibiotic concentrations used for determining MICs is universally accepted to be in 
doubling dilution steps up and down from 1 mg/L as necessary[27]. 
Antonio Carta et al[28], reported the activity of 3-methyl-9-substituted-6-oxo-6,9-
dihydro-3H-(1,2,3)-triazolo(4,5-h)quinolone-carboxylic acids and their esters as a new 
class of anti-infective agents against MDR M. tuberculosis, with no cytotoxicity reported. 
 
2.1.1.3.Antiviral Activity 
Viruses are small infectious agents that replicate only inside the living cells of an 
organism and can infect all types of organisms, from animals and plants to bacteria[29]. 
Viruses such as Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) belong to 
the Herpesviridae family, are double-stranded DNA[30], and share high homology in 
genome structure and DNA sequence. These viruses can cause various illnesses states from 
assymptomatic infection to fulminant disseminated diseases, including labials herpes, 
keratitis (cornea inflammation), genital herpes, and encephalitis[31, 32]. 
There are a wide number of drugs for treatment of HSV infections like acyclovir, 
ganciclovir, penciclovir, valaciclovir (converted to acyclovir) and famciclovir (converted to 
penciclovir)[30, 33], being acyclovir the most common drug used. However, there are 
drug-resistant strains of HSV emerging and increasing[30, 34], leading to the search of new 
antiviral drugs. 
Quinoxalines have a variable antiviral activity, suggesting that their activity depends 
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on specific substitution patterns. Novel series of al 6H-indolo-(2,3-b)quinoxalines were 
synthesized and evaluated for antiherpes virus activity and the compound 2,3-
dimethyl(dimethylaminoethyl)5H-indolo-(2,3-b)quinoxaline had the major antiviral 
activity. This specific compound was tested for its antiviral effect and action mechanism, 
showing the capacity to inhibit replication of HSV-1, cytomegalovirus, and varicella-zoster 
virus in tissue culture, in concentrations of 1 to 5µM, depending on the virus amount and 
cell type used in the assay. Also the compound 2,3-dimethyl-6-(dimethylaminoethyl)-6H-
indolo-(2,3-b)quinoxaline (Figure 4) presented high activity against HSV, and derivatives 
with 6-(2-dimethylaminoethyl) side chain, due to their DNA binding properties, showed an 
improved biological activity[1]. 
 
Figure 4: 2,3-dimethyl-6-(dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline compound: a) Lewis structure; 
b) non-optimized 3D structure. 
There is also reference to IndQloquinoxalines with capacity to inactivate virions in 
high concentrations (around 300µM), and decrease the synthesis of viral DNA and protein 
at lower concentrations (around 3µM)[16]. 
Concerning human immunodeficiency virus type 1 (HIV-1), which is the agent 
causative of acquired immunodeficiency syndrome (AIDS)[35-37], there are a wide 
number of clinical drugs used to fight the disease, such as non-nucleoside reverse 
transcriptase (RT) inhibitors, which interact with a specific allosteric non-substrate binding 
site on HIV-1 RT[13]. Compound 6-chloro-3,3-dimethyl-4(isopropenyloxycarbonyl)-3,4-
dihydroquinoxalin-2(1H)-thione (Figure 5) was synthesized and evaluated for enzyme 
activity, and was found to be a very potent inhibitor for both HIV-1 RT activity and HIV-1 
replication in tissue cultures. Although, like some other non-nucleoside RT inhibitors, this 
a) b) 
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compound was not effective against human immunodeficiency virus type 2 (HIV-2 
RT)[16].  
 
Figure 5: 6-chloro-3,3-dimethyl-4(isopropenyloxycarbonyl)-3,4-dihydroquinoxaline-2(1H)-thione 
compound: a) Lewis structure; b) non-optimized 3D structure. 
Also, an in vitro fluorescence polarization assay demonstrated that a library of 
quinoxaline derivatives, prepared to target non-structural protein 1 of influenza A (NS1A), 
disrupted the dsRNA-NS1A interaction to varying extents, which lead to the development 
of anti-influenza drugs[38]. 
 
Figure 6: 2,3-difurylquinoxaline-4-(R)methylcarboxamide: a) Lewis structure; b) non-optimized 3D 
structure. 
In this study, investigators have prepared a library based on 2,3-difuryl-4-
quinoxaline(R)metilcarboxamide derivatives (Figure 6), with 2-furyl groups at position 2 
and 3 and phenyl group in position 6 through an amide linker. Among all the compounds in 
the library, compounds listed in Table 2 have shown the highest potency. These 
compounds do not inhibit NS1A-dsRNA interactions by interfering with dsRNA but by the 
binding to NS1A dsRNA-binding domain itself. Also, the compound 2 was able to inhibit 
influenza A virus growth[38]. 
a) b) 
a) b) 
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Table 2:  Activities of amide derivatives of 2,3-difurylquinoxaline-4-(R)methylcarboxamide compound[38]. 
Compound R 
% Binding at 
50µM 
% Intercalation at 50 
µM 
IC50 
µM 
1 3-OMe-Ph- 74,0 4,5 6,2 
2 2-Furyl- 79,5 5,9 3,5 
 
2.1.1.4.Antifungal Activity 
Prevalence of fungal diseases has increased significantly in the past 50 years. Fungal 
diseases manifest themselves differently, including mycoses in the skin, hair, nails, but also 
as systemic mycoses, being the last one an issue of great medical concern due to the 
increase in the immunocompromised patient population[39]. 
One of the most common fungal infections is candidiasis, caused by Candida 
albicans, a diploid fungus that grows both as yeast and filamentous cells[40, 41]. This 
fungus can also develop resistance to antimycotic drugs that already exist in the 
market[42], being important a constant search for new drugs and treatments. 
Thieno(2,3-d)pyrimidines and pyrrolo(3,4-b)quinoxalines were synthesized and 
tested against C. albicans, and presented antifungal activity [13, 19]. 
Researchers also reported some 2-sulphonylquinoxalines and 3-
[(alkylthio)methyl]quinoxaline-1-oxide derivatives as compounds with high antifungal 
activity[9], and also pyrazoloquinoxalines which were observed to be active against fungal 
infections[1].  
 
2.1.1.5.Antiamoebic Activity 
Entamoeba histolytica is a protozoan responsible for the amoebiasis infection[43, 
44], causing amoebic colitis, brain and liver abscess, being the second leading cause of 
death worldwide. The traditional treatment used is based in antiamoebic compounds such 
as nitroimidazoles, but not always effective, raising the possibility of drug resistance, 
leading to the search of new compounds able to fight the infection successfully[45].   
Some 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazolines derivatives 
produced (Figure 7), were found to be a potent inhibitor of HM1:IMSS strain of E. 
histolytica, where the presence of 3-bromo or 3-chloro substituents on the phenyl ring and 
4-methyl group on the pyrazoline ring affected antiamoebic activity to a great extent[45].  
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Figure 7: 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazolines core: a) Lewis structure; b) non-
optimized 3D structure. 
In this study metronidazole was used as the reference drug and had a 50% inhibitory 
concentration (IC50) ranging from 1.69 to 1.82 µM, and compound 6 showed great 
effectiveness, being the most active (Table4)[45]. 
 
Table 3: In vitro antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2 pyrazolines 
derivatives against HM1:IMSS strain of Entamoeba histolytica (aStandard Deviation) [45]. 
Compound R
1
 R
2
 IC50 µM SD
a
 
1 H H 6,76 0,20 
2 Br H 4,98 0,11 
3 Cl H 1,09 0,08 
4 H CH3 2,34 0,23 
5 Br CH3 1,45 0,14 
6 Cl CH3 0,72 0,10 
Metronidazole   1,69 0,24 
 
2.1.1.6.Antileishmanial and Antimalarial Activity 
Leishmaniasis is a parasitic disease cause by protozoan of the genus Leishmania in 
tropical and subtropical areas of the World, and despite all efforts to fight this disease 
about 1-2 million new cases are registered every year[16, 46]. Most of the drugs available 
against leishmaniasis are expensive and require a long treatment and are becoming more 
and more ineffective[11]. 
Malaria is also a tropical parasitic disease, cause by Plasmodium falciparum, leading 
to over a million deaths annually, and rising, probably due to a resistance increasing, 
requiring the development of cheaper and more effective drugs[11, 47-49]. 
Carlos Barea, et al[11], synthesized 14 new 3-amino-1,4-di-N-oxide quinoxaline-2-
carbonitrile derivatives. These compounds were evaluated for their in vitro antimalarial and 
antileishmanial activity against P. falciparum (Colombian FCR-3 strain) and Leishmania 
a) b) 
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amazonensis (strain MHOM/BR/76/LTB-012A). The study showed that compounds with 
one halogenous group in position 6 and 7 provide an efficient approach for further 
development of antimalarial and antileishmanial agent. 
 
2.1.2.Antidiabetic Activity 
Diabetes Mellitus is a disease caused by the dysfunction of glucose homeostasis, in 
which glucose levels appear abnormal with tendency to hyperglycemia. Diabetes type 1 is 
insulin-dependent and requires a daily subcutaneous injection of insulin, while diabetes 
type 2 is non-insulin-dependent and can be treated with several drugs such as 
sulfonylureas, nateglinide, biguanides, etc. However these treatments have limited efficacy 
and tolerability, and could cause severe side effects[50]. In this regard, new transition 
metal complexes of quinoxaline-thiosemicarbazone ligands L
1
H2 and L
2
H2 were prepared 
(Figure 8). The ligands were explored with copper and zinc complexes in diabetes induced 
Wister rats. The compounds [ZnL
1
(H2O)] and L
2
H2 have showed prominent reduction in 
blood glucose level and the complexes [CuL
1
(H2O)], [ZnL
1
(H2O)] and [CuL
2
(H2O)] have 
exhibited good activity in oral glucose tolerance test (OGTT) and showed low toxicity[12].  
 
Figure 8: Ligands L1H2 and L
2H2. For L
1H2, R=CH3 and for L
2H2, R=C6H5: a) Lewis structure; b) non-
optimized 3D structure. 
Also (N-arylcarbamoyl and N-aryl thiocarbamoyl) hydrazinequinoxaline-2(1H) 
(Figure 9) have been reported as mild hypoglycaemic agents[1]. 
a) b) 
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Figure 9: (N-arylcarbamoyl and N-aryl thiocarbamoyl) hydrazinequinoxalin-2(1H) compounds: a) Lewis 
structure; b) non-optimized 3D structure. 
2.1.3.Anti-inflammatory Activity 
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in therapeutics, 
generally for the treatment of pain and inflammation, but its long-term usage can lead to 
significant side effects like gastrointestinal lesions, bleeding, and nephrotoxicity. Due to 
those reasons mentioned it is important the discovery of new safer anti-inflammatory drugs 
[51-53]. 
Quinoxaline 1,4-di-N-oxide derivatives such as 4-(7-fluoro-3-methyl-quinoxalin-2-
yl)-6-(3,4,5-trimethoxy-phenyl)-pyrimidin-2-ylamine and 2,6,7-trimethyl-3-[5-(3,4,5-
trimethoxy-phenyl)-4,5-dihydro-1H-pyrazol-3-yl]-quinoxaline, showed an in vivo anti-
inflammatory effect, higher than one reference drug, IMA (indomethacin), and in vitro 
decreasing values of LOX (lipoxygenase). LOX is an enzyme essential to arachidonic acid 
(AA) metabolism, which leads to the formation of leukotrienes, a type of pro-inflammatory 
mediator involved in processes like fever, asthma and cardiovascular disease[54, 55]. It 
was demonstrated that the incorporation of pyrimidine, thiazolopyrimidine, 
pyrazolopyridine, pyridopyridine, p-chlorophenyl, p-methoxyphenyl or pyridine nucleus to 
quinoxaline moiety cause significant anti-inflammatory activity, and also analgesic 
activity[51]. 
 
2.1.4. Anticancer Activity 
Cancer is the main cause of death in developed countries nowadays, and the second 
cause of death in developing countries, result of population aging and growth, and the 
adoption of lifestyle choices, included in risk factors to cancer development, such as 
smoking, physical inactivity and diet[56, 57].  
a) b) 
COMPUTATIONAL ANALYSIS OF QUINOXALINES N,N-DIOXIDE AND ITS DERIVATIVES 
 
18 
 It is known that quinoxaline nucleuses exhibit potential anticancer activity, which 
makes them an important basis for the anticancer drugs[16]. A new series of 2-
alkylcarbonyl and 2-benzoyl-3-trifluromethylquinoxaline-1,4-di-N-oxide derivatives was 
synthesized and evaluated for in vitro antitumor activity against a 3-cell line panel (MCF7 
(breast), NCIH 460 (lung) and SF-268 (CNS)), and then evaluated in a full panel of 60 
human tumor cell lines, derived from nine cancer cell types (Leukemia, Non-small cell 
lung cancer, Colon cancer, CNS cancer, Melanoma, Ovarian cancer, Renal cancer, Prostate 
cancer and Breast cancer). It was showed that, in general, anticancer activity depends on 
the substituents in the carbonyl group, increasing the activity in the order: 
ethyl<isopropyl<tert-butyl<phenyl-ones. Among these the compounds (Figure 10) 2-
isobutyryl-3-trifluoromethylquinoxaline-1,4-di-N-oxide (Compound 1), 2-benzoyl-6,7-
dichloro-3-trifluoromethylquinoxaline-1,4-di-N-oxide (Compound 2), their diﬂuorinated 
analogs (6,7-diﬂuoro-2-isobutyryl-3-triﬂuoromethylquinoxaline-1,4-di-N-oxide and 2-
benzoyl-6,7-diﬂuoro-3-triﬂuoromethylquinoxaline-1,4-di-N-oxide)  (Compound 3 and 4), 
and 2-(2,2-dimethylpropanoyl)-3-trifluoromethylquinoxaline-1,4-di-N-oxide (Compound 
5) were the most active, with higher anticancer activity with mean GI50 values of 1.02, 
0.42, 0.52, 0.15, and 0.49 µM, respectively (Table 5)[10, 16]. 
 
 
Compound 1: 2-Isobutyryl-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 2: 2-benzoyl-6,7-dichloro-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
a) 
b) 
a) b) 
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Compound 3: 6,7-diﬂuoro-2-isobutyryl-3-triﬂuoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 4: 2-benzoyl-6,7-diﬂuoro-3-triﬂuoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 5: 2-(2,2-dimethylpropanoyl)-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
Figure 10: Compounds 1 to 5: a) Lewis structure; b) non-optimized 3D structure. 
Table 4: In vitro inhibitory activity test for compounds against 60 human tumor cells lines[10]. 
Compound IG50 µM 
1 1,02 
2 0,42 
3 0,52 
4 0,15 
5 0,49 
 
2.1.5.Antiglaucoma Activity 
Glaucoma is the designation to refer the diseases that affect the optic nerve, 
involving the loss of retinal ganglion cells in a characteristic pattern of optic neuropathy 
and excavations of the nerve head[58-60]. Almost 67 million people worldwide are 
a) b) 
a) b) 
a) b) 
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affected by glaucoma, remaining the leading cause of irreversible blindness, responsible 
for 14% of blindness after cataract and trachoma[61, 62]. 
Alphagan
®
 (Brimonidin) is a relatively selective alpha-2 adrenergic receptor agonist, 
and its composition consists in (5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxaline 
(Figure 11). This drug works as an antiglaucoma agent, due to its power to reduce the 
intraocular pressure, alleviating the symptoms of glaucoma[1, 16]. 
 
Figure 11: Alphagan chemical structure: a) Lewis structure; b) non-optimized 3D structure. 
2.1.6.Antiproliferative Activity 
Atherosclerosis is responsible for 50% of all mortality in the USA, Europe and 
Japan, is the principal cause of heart attack, stroke and gangrene of the extremities[63]. 
After artery injury, abnormal proliferation and migration of vascular smooth cells (SMCs) 
into the intimal layer of the arterial wall occurs, proliferating and synthesizing extracellular 
matrix components, playing an important role in coronary artery atherosclerosis and 
restenosis after an angioplasty[64, 65].  
 A series of 6-arylamino-2,3-bis(pyridin-2-yl)-7-choloroquinoxaline-5,8-diones 
(Figure 12) were synthesized and screened for their inhibitory activity on rat aortic smooth 
muscle cell  (RAoSMC) proliferation. IC50 values were determined and compared to the 
positive control mycophenolic acid
 
(MPA) (Table 6), and most of the compounds showed 
good activity, and the quinoxaline-5,8-diones  was found as an potent antiproliferative 
agent[1, 16, 66]. 
a) b) 
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Figure 12: 6-arylamino-2,3-bis(pyridin-2-yl)-7-choloroquinoxaline-5,8-diones compounds: a) Lewis 
structure; b) non-optimized 3D structure. 
Table 5: Structures and IC50 values of 6-arylamino-2,3-bis(pyridin-2-yl)-7-chloro-quinoxaline-5,8-diones for 
inhibition of SMC proliferation[66]. 
Compound R
1
 R
2
 R
3
 SMC IC50 (μM) 
2a H Cl H 1.5 
2b H OH H 5.5 
2c H F H 1.0 
2d H CF3 H 1.1 
2e H OCF3 H 1.0 
2f H OCH3 H 3.5 
2g H H H 3.1 
2h Cl Cl H 1.0 
2i F F F 1.2 
4 
   
>100 
MPA 
   
1.0 
 
2.1.7.Antidepressant Activity 
5-hydroxytryptamine (5HT), commonly known as serotonin, is a neurotransmitter 
involved in a great number of physiological and patho-physiological processes, acting 
through the receptor subtypes, which are 5-HT1 to 5-HT7. Almost all of the receptors 
subtypes belong to the family of G-protein coupled receptor (GPCR), but the specific 
receptor subtype 5HT3 is a ligand gated ion channel[67, 68]. The antagonists to this 
receptor lead to various responses, such as anti-emetic action in cancer chemo-/radio-
therapy induced nausea and vomiting, anti-depressant, anxiolytic, anti-phsycotic and anti-
inflammator. The drugs available to depression conditions have a delayed onset of action, 
which emphasizes the demand of new antidepressant drugs, with a safer and faster 
action[67, 68]. 
New series of structurally novel 3-substituted-2-carboxamides quinoxaline were 
designed as 5-HT3 receptor antagonists using ligand-based approach. All the compounds 
synthesized exhibited 5-HT3 receptor antagonism, and some of them showed antagonism 
a) b) 
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greater than the standard drug, Ondansetron, like (3-ethoxyquinoxalin-2-yl)(4-
methylpiperazin-1-yl)methanone and N-(2-(1H-indole-3-yl)ethyl)-3-ethoxyquinoxaline-2-
carboxamide[68].  The compound N-{3-[(4-methylpiperazin-1-yl)methyl]-4-
hydroxyphenyl}-3-methoxyquinoxalin-2-carboxamide showed most favorable 5-HT3 
receptor antagonism[16]. 
Also 3-benzyl-2-substituted quinoxalines were synthesized as novel monoamine 
oxidase (MAO) A inhibitors. The MAO inhibitors are very useful for the treatment of 
several neurological diseases, like Parkinson and depression. MAO-A inhibitors are used as 
antidepressant and antianxiety drugs. In this study, the final compounds were evaluated for 
their MAO-A inhibitory activity in vitro, using serotonin as substrate[13]. 
 
2.1.8.Anti-exocitotoxicity activity of glutamate 
A major excitatory neurotransmitter in the central nervous system in mammalian 
species is the glutamic acid, an excitatory amino acid (EAA). Overstimulation of the 
postsynaptic glutamate receptors occurs, due to a high release of EAA, could result in 
neuronal death, and consequently induce neurodegenerative disorders such as Alzheimer 
and Huntington’s disease[69-73]. AMPA-R (α-amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid receptor) antagonists have showed to have no side effects such as 
schizophrenia and protective activity in neural death, and many quinoxalinedione 
derivatives with competitive AMPA-R antagonistic activity have been synthesized and 
tested against the EAA receptor[74]. 
The compound 7-[4-[N-[4-carboxyphenyl]carbamoyloxy]methyl]imidazolyl]-3,4-
dihydro-6-nitro-3-oxo-quinoxaline-2-carboxylic acid (GRA-293) was identified as a novel 
AMPA-R antagonist due to its high potency and good selectivity in vitro, and its potent 
neuroprotective effects in an animal model in vivo, higher than the known 
quinoxalinedione compounds used. These effects are due to a novel substituent, namely 
substituted benzene ring with urethane linkage to imidazole, in C-7 position, which leads to 
a potent AMPA-R affinity and contributes to therapeutic efficacy in animal models. This 
compound, with such charactereristics, meets the criteria, in an injectable formulation, for 
use in the treatment of acute cerebral ischemia[74]. 
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2.2.Industrial applications 
In industry, the quinoxalines and derivatives have also various applications. They can 
be used to prevent metal corrosion, leading to a decrease in maintenance of some materials 
and equipment, and can be used as host materials in some light-emitting diode (LED) 
lights, for example. 
2.2.1.Corrosion Inhibition 
The use of acid solution is very common in industry, and has important fields of 
application like acid pickling, industrial acid cleaning, acid descaling and oil well 
acidizing. However, the continuous use of acid solutions can lead to the metal corrosion, 
leading to enormous economic losses, thence the importance of having inhibitors to 
minimize the metal dissolution and acid consumption, instruments malfunction and 
contamination[5, 75].  
 The most effective inhibitors used in industry to minimize these losses are organic 
compounds. Their inhibitory effect is reinforced by the presence of heteroatoms such as 
sulphur, nitrogen and oxygen, which will facilitate its adsorption on the mild steel surface 
following the sequence S>N>O[3, 75]. 
Other studies revels that the adsorption in mild steel surface also depends on the 
physicochemical properties of the inhibitor group, planarity of the system, presence of 
multiple adsorption active centers with lone pair and/or π orbitals, molecular size and 
electronic density at the donor atom. On this basis, the choice of effective inhibitors is done 
taking in consideration their structure, their mechanism of action and their electron 
donating ability[3]. Many N-heterocyclic organic compounds are good corrosion inhibitors, 
but some of them are highly toxic to both human beings and environment, leading to a 
continue search for an eco-friendly and harmless N-heterocyclic compounds as 
inhibitors[76].  
Quinoxaline derivatives are N-heterocyclic aromatic compounds that have been 
proved to be excellent corrosion inhibitors for mild steel in acidic media, easy to 
synthesized and ready available[77]. 
Compound 2,3-quinoxalinedione (QD) (Figure 13) was used to study its corrosion 
inhibition properties for mild steel in 1M HCl, due to the presence of heteroatoms N and O, 
and π-electrons. It was shown that QD can act as a good corrosion inhibitor for mild steel 
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in 1M HCl, with an inhibition efficiency of 88% at 10
-3
M (measured through weight 
loss)[75]. 
 
Figure 13: 2,3-quinoxalinedione compound: a) Lewis structure; b) non-optimized 3D structure. 
 
Indeno-1-one [2,3-b] quinoxaline (INQUI) (Figure 14), was synthesized and tested 
for inhibition corrosion of mild steel in 0,5M H2SO4, and showed about 81% of inhibition 
efficiency at 10
-6
M. This efficiency increases with INQUI concentration but decreases with 
immersion time[76]. 
 
 
Figure 14: Indeno-1-one [2,3-b] quinoxaline (INQUI) compound: a) Lewis structure; b) non-optimized 3D 
structure. 
 
Also acenaphtho [1,2-b] quinoxaline (AQ) (Figure 15) was tested as a corrosion 
inhibitor for mild steel in 0,5 M H2SO4. AQ acts as an effective inhibitor for mild steel in 
acidic medium, with 80% of inhibition efficiency at 10
-6
M (measured through weight 
loss)[77]. 
 
a) b) 
a) b) 
COMPUTATIONAL ANALYSIS OF QUINOXALINES N,N-DIOXIDE AND ITS DERIVATIVES 
 
25 
 
Figure 15: Acenaphtho [1,2-b] quinoxaline (AQ) compound: a) Lewis structure; b) non-optimized 3D 
structure. 
 
Quinoxaline derivatives, namely 3-methyl-2-phenyl quinoxaline (MPQ), 2,3-
diphenyl quinoxaline (PPQ), 3-methyl-2(2-hydroxyphenyl)quinoxaline (MHPQ), 3-phenyl-
2(2-hydroxyphenyl)quinoxaline (PHPQ) and 3-methyl-2(3-methoxy,4-
hydroxyphenyl)quinoxaline (MMtHPQ), have been shown through experimental studies to 
have high corrosion inhibition efficiencies for copper in nitric acid, with the order of 
inhibition efficiency being MMtHPQ > PPQ > MPQ > PHPQ > MHPQ[5]. 
 
2.2.2.Cu
2+
 detection 
Cu
2+ 
is a transition-metal ion, crucial in the life processes, since it has an important 
role as a catalytic cofactor for a variety of metallo-enzymes such as superoxide dismutase, 
cytochrome c oxidase, lysyl oxidase and tyrosinase, etc. However when overloading, 
exhibit toxicity and could cause a variety of neurological diseases. Besides, it is also 
important in pollution matters, since the formulation of copper-containing pesticides uses 
various forms of copper, which in the end dissociates into Cu
2+
[78, 79].   
There are technologies well developed to detect Cu
2+
 such as inductively  coupled  
plasma  detectors, surface-plasmon  resonance  detectors,  ﬂuorescence  anisotropy assays,  
quantum-dot-based  assays,  electrochemical  sensors  and fluorescence sensors. These are 
technologies with high sensitivity and speciﬁcity for Cu2+ detection, but also very 
expensive, due to the need of sophisticated instruments and highly trained operators. On 
the other hand, it is possible to use a naked-eye detection method, which gives a more fast 
response without involving any costly instrument, although it is a method with lower 
sensitivity and only give a qualitative response[79]. 
A colorimetric receptor  ninhydrin–quinoxaline  based  was  designed,  synthesized  
a) b) 
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and  characterized, and  exhibited  high  sensitivity  and  selectivity  for  Cu
2+
 in  aqueous  
medium  over  a  wide  variation  of  cations  such  as  Na
+
,  Mg
2+
,  Al
3+
,  Co
2+
,  Fe
3+
,  Ni
2+
,  
Zn
2+
,  Cd
2+
,  Hg
2+
 and  Pb
2+
. In this study Cu
2+
 was added  to  the  receptor  solution  giving 
a  clear  colour  change  from  olive  green  to  pink.  The detection  limit was  found  to  be  
3,43  ×  10
−7
 M  which  is  one of  the  lowest for  the  Cu
2+
 in  an  aqueous  solution  by  
any  naked-eye  receptor[79].  
 
2.2.3.OLED - organic light-emitting diode 
Phosphorescent OLEDs (PHOLEDs) are well known due to its high efficiency 
(possibility of 100% internal quantum efficiency)[80], leading to the research and synthesis 
of new compounds and materials as hosts, charge transporting materials and emitters. The 
high efficiency is due to PHOLED capacity to harvest both singlet and triplet excitons for 
light emission[81, 82]. However, triplet emitters tend to decrease the efficiency because of 
the triplet-triplet annihilation concentration during device operation despite of owing long 
emissive lifetimes. The solution is to develop new bipolar host materials, which will 
contribute to the balanced transport of carriers and help to increase the probability of 
carrier recombination, and will grant better device stability due to its amorphous 
nature[82].  
New series of carbazole/quinoxaline hybrids with 1,3,5-benzene core have been 
synthesized, and showed excellent thermal and morphological stabilities, due to their 
twisted geometry. These compounds, bipolar along with high thermal stability and 
favorable electrochemical properties, are promising for their use as host materials in red 
and green phosphorescent based OLEDs[82]. 
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Chapter III: 
Computational Chemistry   
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3.Computational Chemistry 
In this chapter is made an introduction to the computational chemistry and an 
overview to the most important topics to this study. 
3.1.An introduction to Computational Chemistry 
Computational chemistry is the science, or art, that is a natural branch of theoretical 
chemistry[83], and is used to represent molecular structures, simulating their behavior with 
classic and quantum physics equations. Computational chemistry programs allow scientists 
to generate and present molecular data, such as geometries (bond length, bond angles, and 
torsion angles), energy (activation energy, etc) electronic properties (ionization potential, 
charges, electronic affinity, etc) spectroscopic properties (vibration, shifts), and mass 
properties (volumes, viscosity, diffusion, etc). However, it is necessary, from the 
investigator, intuition and training to understand the results more properly, being these 
results measure up with experimental data, when available, which is a very important tool 
to guide both laboratorial and computational work[84]. 
Computational chemistry is a well developed method and can be automated. 
However, few chemical aspects can be precisely processed at computational level, whereas 
results are described in a qualitative and approximately quantitative computational 
scheme[85]. The Schrödinger equation is the basis for most of the computational chemistry 
because it  models the atoms and molecules with mathematics[86]. 
Currently, to determine molecular properties, there are three quantum approaches: ab 
initio methods, semi-empiric methods and methods based on Density Funcional Theory 
(DFT)[87, 88]. 
 
3.1.1.Quantum Chemical Models 
The quantum  models refer electrons not as particles, but as waves and its 
features[86]. Models such as Shrödinger equation and Hartree-Fock Approximation, which 
will be explained next, are examples of quantum chemical models used to describe a 
wavefunction of a physical system. 
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3.1.1.1. Shrödinger equation 
Shrödinger equation, also called the Schrödinger wave equation, is a partial 
differential equation that describes how the wavefunction of a physical system evolves 
over time[89]. 
Quantum mechanics describes molecules and molecular geometry in terms of 
interactions between nuclei and electrons, and in terms of minimum energy arrangements 
of the nuclei, respectively. All quantum mechanical methods ultimately trace back to the 
Shrödinger equation, which is represented next. 
 
Ĥᴪ = Eᴪ 
This Shrödinger equation is for multinuclear and multielectron systems. The ᴪ 
represents a many-electron wavefunction and Ĥ represents the Hamiltonian operator, 
which in atomic units is given by. 
 
 
In here, Z is the nuclear charge, MA is the ratio of mass of nucleus A to the mass of 
an electron, RAB is the distance between nuclei A and B, rij is the distance between 
electrons i and j and riA is the distance between electron i and nucleus A. 
However, the many-electron Shrödinger equation cannot be solved exactly, even for 
a two-electron system, and approximations to the equation are needed to provide practical 
methods[90]. 
 
3.1.1.2. Hartree-Fock Approximation 
The Hartree Fock (HF) method expresses the total wavefunction of the system as a 
product of one-electron orbitals, and in this method, the wavefunction is an 
antisymmetrized determinantal product of one-electron orbitals (Slater determinant). Due 
to the impossibility (so far) to solve the Shrödinger equation, this one is transformed into a 
set of HF equations. The HF equation is also known as the self-consistent field (SCF) 
method[86, 90]. 
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This method begins with a set of approximate orbitals for all the electrons in the 
system. After that, one electron is selected, and the potential in which it moves is 
calculated by freezing the distribution of all the other electrons and treating their averaged 
distribution as the centrosymmetric source of potential. The Schrödinger equation is solved 
for this potential, which gives a new orbital for it, and the procedure is repeated for all the 
other electrons in the system, using the electrons in the frozen orbitals as the source of the 
potential. At the end of one cycle, there are new orbitals from the original set, and the 
process is repeated until there is little or no change in the orbitals.[86] 
 
3.1.2.Quantum Approches 
Before start any investigation, we have to take into account the compound, and the 
results we expect in order to choose the better method. The most important methods, and 
the most used, are the ab initio, semi-empirical and DFT methods. 
3.1.2.1. ab initio methods 
ab initio methods are the methods obtained directly from classic physic theoretical 
principles, without any inclusion of experimental data[85, 87] and provides a systematic 
pathway toward the exact solution of the Schrödinger equation[91]. The more common ab 
initio type of calculation ab initio more common is called Hartree-Fock, where elctron-
electron repulsion is not taking in account, being an approximation method for the wave 
determination, in the fundamental state of energy. These methods provide, generally, good 
qualitative results and are able to provide quantitative results each time more precise, as 
the molecules in question decrease in size[85]. 
For molecular systems of larger dimensions it was necessary the introduction of 
simplification in the ab initio methods, leading to the semi-empiric methods group[87]. 
3.1.2.2. Semi-empirical methods 
Semi-empirical methods are simplified versions of HF theory using empirical 
corrections (derived from experimental data) in order to improve the performance. This 
method only takes into account the valence electrons and their respective orbitals[87], and 
is faster than ab initio methods
 
[85]. 
Modeling tools have been widely applied for theoretical studies of various organic 
molecules with π-conjugated electron systems, in semi-empirical methods[92-94]. The 
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most popular semi-empirical methods are Austin Method 1 (AM1), Parameterization 
Method 3 (PM3) and Modified Neglect of Differential Overlap (MNDO). Recently, a new 
semi-empirical method named Recife Model 1 (RM1), being essentially an extensive re-
parameterization of AM1, has come to use[92, 95]. 
3.1.2.3. DFT methods 
DFT methods came up as the solution for molecular systems of large dimensions, 
treating the electronic correlation in a faster way
 
[87]. These methods are a valuable 
research tool since they allow to validate conclusions achieved by experimental methods or 
to distinguished between probabilities left open. The calculation of a wide range of 
molecular properties with DFT methods allows a straight conection between the theory and 
experimental work, and conduct to important clues about geometry, electronic and 
spectroscopic properties[96]. 
The DFT principle is based on the idea that the energy of an electronic system can be 
described in terms of the electronic density probability ρ. The electronic energy E, is a 
functional of electronic density, designated by E[ρ]. In this case one function ρ(r) 
corresponds to a single energy[87, 97]. This method is similar to the Schrödinger equation 
resolution, from which it follows that also has a detailed theory in the electronic structure 
and matter properties descriptions. 
The pure DFT methods are defined through the combinations of exchange functional 
with a correlation functional. For example, the BLYP functional combine the exchange 
functional from Becke (B) gradient-corrected with the correlation functional Lee, Yang 
and Parr gradient-corrected (LYP). 
The hybrid DFT methods are defined through the combination of the HF exchange 
term, which reflects the exchange interaction between electrons with equal spins and 
exchange-correlation functional of DFT. Currently the most widely used functional hybrids 
are functionals developed by Becke. 
The Becke functionals hybrids have the general form: 
DFT
xDFT
HF
xHFxc ECECE 
hib  
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In this equation, HFC  and DFTC  are constants. For example, the Becke hybrid 
functional with three parameters (B3LYP), LYPBxcE
3 , can be defined by the equation: 
)EE(CEEC)EE(CE VWNc
LYP
cc
VWN
c
B
xx
LDA
x
HF
x
LDA
x
3388
0   
In here, 2000 .C  , 720.Cx   e 810.Cc  . As this equation shows, the B3LYP 
hybrid method includes a misture of HF exchange terms and DFT, associated with the 
gradient-corrected correlation functional. From all recent functionals, the B3LYP remains 
the most popular due to its extremely high global performance[87]. 
 
Figure 16:  Classification of computational chemistry methods[98]. 
Table 6: Specifics of ab initio, semi-empirical and DFT methods. 
Method Advantages Disadvantages Best for 
a
b
 i
n
it
io
[9
9
] - Uses quantum physics 
- Mathematically rigorous, no 
empirical parameters 
- Uses approximation extensively 
- Useful for a broad range of 
systems 
- Computationally 
expensive 
- Small systems (tens 
of atoms) 
- Systems involving 
electronic transitions 
- Molecules or 
systems without 
available 
experimental data 
("new" chemistry) 
- Systems requiring 
rigorous accuracy 
Methods in 
Computational 
Chemistry
Classical
Molecular 
Mechanics
Quantum 
Mechanical
Wave Function 
Base
Semi-empirical
ab initio
DFT
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S
em
i-
E
m
p
ir
ic
a
l[
9
9
] - Uses quantum physics 
- Uses experimentally derived 
empirical parameters 
- Uses approximation extensively 
- Less demanding 
computationally than ab initio 
methods 
- Capable of calculating transition 
states and excited states 
- Requires 
experimental data 
(or data from ab 
initio) for 
parameters 
- Less rigorous 
than ab initio) 
methods 
- Medium-sized 
systems (hundreds of 
atoms) 
- Systems involving 
electronic transitions 
D
F
T
 
- Increase in computational 
accuracy without additional 
increase in computing time 
- Does not depend on 
experimental data 
- Capable of calculating transition 
states and excited states[99] 
- Hard to determine 
the most 
appropriate method 
for a particular 
application[99] 
- Molecular systems 
of large 
dimensions[87] 
 
 
3.2.Software 
There are some softwares in the market used in computational chemistry. The 
softwares that will be used to analyze quinoxalines are the Gabedit and Gaussian. 
 
3.2.1.Gabedit 
Gabedit is a free graphic interface which offers an adapted pre and pos-processing to 
new computational chemical software packages, such as Gamess-US, Molcas, Gaussian, 
Molpro and MPQC. This software includes edition, visualization, analysis and conversion 
tools, and animated molecular systems. Computational chemistry software files can be 
generated through Gabedit. It is possible to present molecular orbitals, electronic density, 
electrostatic potential, nuclear magnetic resonance density, among other volumetric data 
properties, as Ultraviolet-Visible (UV-Vis), InfraRed (IR) and Raman computed spectra. 
Gabedit also allows to creat Povray files to geometries, surfaces, contour and colour coded 
planes, and animated picture. 
Gabedit includes an advanced Molecule Builder which can be used to draw 
molecules and examine them in three dimensions[100].  
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This interface also will be used to draw and to determine the Z-matrix (nonredundant 
internal coordinates)[101] of all the quinoxaline compounds. Gabedit will generate a input 
file for a computational chemistry software, which will be Gaussian. 
 
3.2.1.1. Z-matrix 
Z-matrix is a simple, although rough, geometrical approximation, good for large 
molecules once they can be converted to Cartesian coordinates. Z-matrix works by 
identifying each atom in a molecule by a bond distance and angle, and dihegral angle 
(angle between two planes) in relation to other atoms in the compound[86, 102]. The Z-
matrix reading will be explained in the Chapter VI. 
 
Figure 17: Z-matrix example of quinoxaline-1,4-dioxide compound, made on Gabedit software. 
3.2.1.2. Basis Set 
For the calculation of the Molecular Orbitals (MOs) the chemist must tell the 
computer some information first, such as geometry (bond lengths and angles, and 
dihedrals), kind of calculations (single point energy, frequency, transition state, electronic 
density, electrostatic potential) and the starting set of mathematics and approximations 
(calculation method (ab initio, semi-empirical or DFT), type of approximation (HF, 
Moller-Plesset,etc.) and basis set approximation). 
In quantum chemistry, the “basis set” usually refers to the set of (nonorthogonal) 
one-particle functions used to build MOs. A MO theory calculation is a mathematical 
expression of an electron in a molecule. There are many types of MO functions, being the 
Slater Type Orbitals (STOs) and the Gaussian Type Orbitals (GTOs) two well known 
functions. There is no significant difference between these two functions when calculating 
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small molecules, but in larger molecules, with 30 or more atoms, the discrepencies come 
up[86]. 
STOs requires more time than GTOs due to the great number of calculations that are 
made. However their calculations were found to be more accurate. Nevertheless, GTOs are 
much faster, and scientists realized that by adding several GTOs, they were able to mimic 
STOs accuracy.  
When using GTOs to model STOs, the new equations are given a new name, and 
identified as STO-xG equations, being the x a constant that represents the number of GTOs 
used. Two common equations are the STO-3G and the STO-6G in which 3 and 6 GTOs are 
used respectively[86].  
 
3.2.2.Gaussian 
Gaussian, a computational chemistry software, allows the calculation of energies, 
geometries, vibrational frequencies, transition states, reaction pathways, excited states and 
a number of properties based in wave functions correlated and non-correlated. This 
software is widely used by chemists, chemical engineers, biochemists, and physics, among 
others. 
Based on quantum mechanic basic laws, Gaussian can predict energies, molecular 
structures, and vibration frequencies of molecular systems, along with several molecular 
properties derived therefrom. This software can be used to study molecules and reactions 
under a wide range of different conditions, including stable species and compounds, which 
are from difficult or impossible observation experimentally, as like as short life 
intermediates and transition structures. Several research groups use Gaussian to perform 
advanced theorical calculations, which are used to predict numerous properties of atoms, 
molecules, radicals, ions, strongly and weakly ligand complexes, among others. Though, 
Gaussian is also widely used to determine structures in equilibrium, IR and Raman 
intensities and frequencies, and to determine the enthalpie calculations of formation from 
several chemical species. It is specially usefull when there are no experimental data 
available, or when is difficult to determine their properties by experimental methods[102, 
103]. 
The Gaussian will be used to optimize geometries of all quinoxalines models 
constructed in Gabedit, using DFT at the B3LYP level with 6-31G** basis set. In this basis 
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set, the interior orbital layer s is represented by three functions, with interior and exterior 
character. The first asterisk means the addition of a complete set of d type Gaussian 
polarization functions for each atom from second period present in the system under study, 
and the second asterisk, the addition of a set of Gaussian functions of p type to each 
hydrogen atoms[87]. 
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Chapter IV: 
Objectives 
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4.Objectives 
This study pretends to determine the molecular properties of the quinoxaline N,N-
dioxide and some of its derivatives, through computational chemistry methods. Being such 
a wide scope, the main objective was refined in the following specific objectives, which 
were the basis for the work timeline: 
1) State of the art review of quinoxalines and its derivatives. 
 This objective allowed a specialization in the quinoxalines features and 
activities, and resulted in an article already submitted in a peer reviewed 
journal, the European Journal of Medicinal Chemistry. 
2) Design the quinoxaline N,N-dioxide and its derivatives in Gabedit and extract the Z-
matrix, as the first step of the computational calculations. 
 This objective was fully reached, and all the Z-matrices were extracted and are 
presented in the results chapter. 
3) Using the Gaussian program, determine the single-point energy of each compound, and 
therefore obtain the numeric value of the potential energy surface. 
 The data files were written and prepared for all the compounds. The specific 
single-points calculations followed and already two reached a successful final. 
The remaining compounds are running at the present time. 
4) Using the Gabedit, analyze various properties of the compounds, to understand their 
different reactivity and compare with biological activity already observed by the 
investigation group. 
 Due to computational logistic, it was not possible to accomplish this specific 
objective in this present work, though the analysis is on course. 
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Chapter V: 
Methods and Materials 
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5.Materials and Methods 
In this section are presented the compounds, materials and methods used in the 
present study. 
5.1.Compounds 
The compounds which will be analysed in this study have been studied previously by 
the research group members, in order to determine their energetic properties as well as 
biological activity. 
Table 7: Compounds under study. 
Compounds 
Quinoxaline 1,4-dioxide 
(QNX) 
2-methylquinoxaline-1,4-dioxide 
(2MQNX) 
2-methyl-3-benzoylquinoxaline-1,4-dioxide  
(2M3BenzoilQNX) 
2-methyl-3-benzylquinoxaline-1,4-dioxide 
(2M3BQNX) 
2-amino-3-cyanoquinoxaline-1,4-dioxide 
(2A3CQNX) 
3-methyl-2-quinoxalinecarboxamide-1,4-dioxide  
(3M2QNXC) 
2-hydroxyphenazine-N-dioxide 
(2HF) 
3-amino-2-quinoxalinecarbonitrile-1,4-dioxide 
(3A2QNXCN) 
3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-
1,4-dioxide (3MN(2MF)QNXC) 
 
5.2.Methods 
The analysis of the quinoxalines and its derivatives will be performed using 
computational chemistry programs. For this were used computers (Hardware: HP Portable 
Computer and Cluster Matheor from Faculty of Science from Porto University) in which 
the necessary softwares are installed to procced to the compounds analysis (Software: 
Gabedit 2.1.0 in HP Portable Computer, and Gaussian on Cluster Matheor from Faculty of 
Science from Porto University).  
Gabedit can be used to draw the compounds and extract the Z-matrices, as the first 
step of the computational calculations. The file extracted from Gabedit can be processed in 
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Gaussian to determine the single-point energy of each compound, and therefore obtain the 
numeric value of the potential energy surface. 
 
Table 8: Hardware and software used in the study. 
Hardware Software 
Portable Computer HP Gabedit 2.1.0 
Super Computer Cluster Matheor: 216 
processors dispersed in 27 nodes with 
the following features: 
- vendor_id : GenuineIntel 
- cpu family : 6 
- model : 30 
- model name : Intel(R) 
Xeon(R) CPU X3430 @ 
2.40GHz 
- cpu MHz : 2394.187  
- cache size : 8192 KB 
Gaussian 
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Chapter VI: 
Results 
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6.Results 
In this chapter it will be presented the design and the respective Z-matrix of each 
compound in study. For the first compound, quinoxaline 1,4-dioxide, is presented also a dat. 
file generated by Gaussian software.  
6.1. Quinoxaline-1,4-dioxide (QNX) 
Results from quinoxaline-1,4-dioxide compound: 3D structure (non-optimized) designed 
in Gabedit (Figure 18); Z-matrix obtained in Gabedit (Figure 19); and dat. file generated by 
Gaussian, after analysis (Figure 20). 
 
Figure 18: Quinoxaline-1,4-dioxide 3D structure (non-optimized), designed in Gabedit software. 
 
Figure 19: Z-matrix of Quinoxaline-1,4-dioxide compound, generated by Gabedit. 
 In Figure 19, the first line specifies an atom, in this case a carbon. The next line lists 
another carbon atom and specifies the internuclear distance between it and the first carbon as 
1,387106 Ångstroms (Å). The third line defines the nitrogen with an N-C distance of 1,332415 
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Å (i.e., from atom 2, which is the second carbon atom) and having an N-C-C angle (with 
atoms 1 and 2) of 120,970461 degrees. After the fourth line all three internal coordinates need 
to be given. It defines the other carbon as bonded to the nitrogen with an C-N distance of 
1,332409 Å, an C-N-C angle of 118,06 degrees (atom 4 - N - atom 2) and a C-N-C-C ( i.e., 
atom 4 - N - atom 2 – atom 1) dihedral angle of  0 degrees. This explanation applies to the 
following Z-matrices. 
After the determination of the Z-matrix, we have calculated the optimized structure. We 
used a dat.file, showed in Figure 20, generated in Gaussian. This dat.file will allow the 
computation of the optimized structure, in order to use it in a single point energy calculation, 
on a subsequent phase, and therefore obtain the energetic parameters pretended. 
In the dat.files, the first line represents the number of processors used in the analysis 
(seven processors in this case); the second line represents the memory extension (500MB); the 
third line the name of the single point; in the fourth and fifth lines are represented the specific 
instructions for the calculation; the sixth line is the file name given by the user; the seventh 
line represents the charge and multiplicity (in this case the charge is 0 and multiplicity 1); the 
remaining lines refers to the optimized Z-matrix of the Quinoxaline-1-4-dioxide compound. 
The instructions for the remaining coumpounds will as follows: 
%nproc=8 
%mem=500MB 
%chk=opt_quinoxalina_2A3CQNX 
#B3LYP/6-31G** opt=(maxcyc=500) scf=(maxcyc=500) TEST. 
The name of the third line, change in accordance with the compound in analysis. 
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Figure 20: dat. file of Quinoxaline-1,4-dioxide generated by Gaussian. 
 
6.2. 2-methylquinoxaline-1,4-dioxide (2MQNX) 
 
Figure 21: 2-methylquinoxaline-1,4-dioxide 3D structure (non-optimized), designed in Gabedit software. 
 
%nproc=7 
%mem=500MB 
%chk=sp_ quinoxaline-1,4-dioxide 
#B3LYP gen pseudo=read sp 
scf=(maxcyc=500,Conver=6)  
#P Gfinput IOP(6/7=3) Pop=full 
 
Quinoxaline-1,4-dioxide (QNX) 
 
0 1 
C 
C       1       dist1 
N       2       dist2   1       ang1 
C       3       dist3   2       ang2    1       died1 
C       4       dist4   3       ang3    2       died2 
N       5       dist5   4       ang4    3       died3 
O       6       dist6   5       ang5    4       died4 
O       7       dist7   6       ang6    5       died5 
C       8       dist8   7       ang7    6       died6 
C       9       dist9   8       ang8    7       died7 
C       10      dist10  9       ang9    8       died8 
C       11      dist11  10      ang10   9       died9 
H       12      dist12  11      ang11   10      died10 
H       13      dist13  12      ang12   11      died11 
H       14      dist14  13      ang13   12      died12 
H       15      dist15  14      ang14   13      died13 
H       16      dist16  15      ang15   14      died14 
H       17      dist17  16      ang16   15      died15 
dist1       1.387106 
dist2       1.332415 
ang1       120.970461 
dist3       1.332409 
ang2       118.059032 
died1       0.000000 
dist4       1.316025 
ang3       118.837252 
died2       -0.631900 
dist5       1.330426 
ang4       126.840180 
died3       1.403764 
dist6       1.251683 
ang5       125.811668 
died4       165.250690 
dist7       5.127817 
ang6       6.228936 
died5       -92.670321 
dist8       4.446039 
ang7       31.076583 
died6       84.288111 
dist9       1.296330 
ang8       90.527948 
died7       -171.168698 
dist10      2.320148 
ang9       91.367475 
died8       0.501411 
dist11      1.358653 
ang10      31.626427 
died9       -176.934461 
dist12      5.955234 
ang11      48.922021 
died10      -3.186188 
dist13      2.548770 
ang12      70.952158 
died11      6.298723 
dist14      5.786219 
ang13      50.482378 
died12      9.951872 
dist15      2.483421 
ang14      110.369655 
died13      -157.421804 
dist16      4.378584 
ang15      89.878202 
died14      -5.112137 
dist17      2.567778 
ang16      30.969139 
died15      -168.678885 
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Figure 22: Z-matrix of 2-methylquinoxaline-1,4-dioxide compound, generated by Gabedit. 
Results from 2-methylquinoxaline-1,4-dioxide compound: 3D structure (non-optimized) 
designed in Gabedit (Figure 21); and Z-matrix obtained in Gabedit (Figure 22). 
 
6.3. 2-methyl-3-benzoylquinoxaline-1,4-dioxide (2M3BenzoilQNX)  
 
Figure 23: 2-methyl-3-benzoylquinoxaline-1,4-dioxide 3D structure (non-optimized), designed in Gabedit 
software. 
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Figure 24: Z-matrix of 2-methyl-3-benzoylquinoxaline-1,4-dioxide compound, generated by Gabedit. 
Results from 2-methyl-3-benzoylquinoxaline-1,4-dioxide compound: 3D structure (non-
optimized) designed in Gabedit (Figure 23); and Z-matrix obtained in Gabedit (Figure 24). 
6.4. 2-methyl-3-benzylquinoxaline-1,4-dioxide (2M3BQNX) 
 
Figure 25: 2-methyl-3-benzylquinoxaline-1,4-dioxide 3D structure (non-optimized), design in Gabedit software. 
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Figure 26: Z-matrix of 2-methyl-3-benzylquinoxaline-1,4-dioxide compound, generated by Gabedit. 
Results from 2-methyl-3-benzylquinoxaline-1,4-dioxide compound: 3D structure (non-
optimized) designed in Gabedit (Figure 25); and Z-matrix obtained in Gabedit (Figure 26). 
6.5. 2-amino-3-cyanoquinoxaline-1,4-dioxide (2A3CQNX)  
 
Figure 27: 2-amino-3-cyanoquinoxaline-1,4-dioxide 3D structure (non-optimized), design in Gabedit software. 
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Figure 28: Z-matrix of 2-amino-3-cyanoquinoxaline-1,4-dioxide compound, generated by Gabedit. 
Results from 2-amino-3-cyanoquinoxaline-1,4-dioxide compound: 3D structure (non-
optimized) designed in Gabedit (Figure 27); and Z-matrix obtained in Gabedit (Figure 28). 
6.6. 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide (3M2QNXC) 
 
Figure 29: 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide 3D structure (non-optimized), design in Gabedit 
software. 
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Figure 30: Z-matrix of 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide compound, generated by Gabedit. 
Results from 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide compound: 3D structure 
(non-optimized) designed in Gabedit (Figure 29); and Z-matrix obtained in Gabedit (Figure 
30). 
6.7. 2-hydroxyphenazine-N-dioxide (2HF) 
 
Figure 31: 2-hydroxyphenazine-N-dioxide 3D structure (non-optimized), design in Gabedit software. 
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Figure 32: Z-matrix of 2-hydroxyphenazine-N-dioxide compound, generated by Gabedit.  
Results from 2-hydroxyphenazine-N-dioxide compound: 3D structure (non-optimized) 
designed in Gabedit (Figure 31); and Z-matrix obtained in Gabedit (Figure 32). 
6.8. 3-amino-2-quinoxalinecarbonitrile-1,4-dioxide (3A2QNXCN) 
 
Figure 33: 3-amino-2-quinoxalinecarbonitrile-1,4-dioxide 3D structure (non-optimized), designed in Gabedit 
software. 
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Figure 34: Z-matrix of 3-amino-2-quinoxalinecarbonitrile-1,4-dioxide compound, generated by Gabedit. 
Results from 3-amino-2-quinoxalinecarbonitrile-1,4-dioxide compound: 3D structure 
(non-optimized) designed in Gabedit (Figure 33); and Z-matrix obtained in Gabedit (Figure 
34). 
6.9. 3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-1,4-dioxide (3MN(2MF)QNXC)  
 
Figure 35: 3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-1,4-dioxide 3D structure (non-optimized), 
designed in Gabedit software. 
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Figure 36: Z-matrix of 3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-1,4-dioxide compound, generated 
by Gabedit. 
Results from 3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-1,4-dioxide 
compound: 3D structure (non-optimized) designed in Gabedit (Figure 35); and Z-matrix 
obtained in Gabedit (Figure 35). 
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Discussion 
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7.Discussion 
The aim of the present study was to analyze, by means of theoretical and computational 
chemistry, quinoxaline N-N-dioxide and the derivatives presented, and to determine some of 
their chemical properties. This work required an extensive analysis about quinoxalines, its 
properties and potentials, resulting in an article (present in the Adendum of this work) 
submitted and render review in a peer reviewed journal, the European Journal of Medicinal 
Chemistry, allowing a tranverse and deep insight about the theme.  
There were used nine quinoxalines: quinoxaline 1,4-dioxide (QNX), 2-
methylquinoxaline-1,4-dioxide (2MQNX), 2-methyl-3-benzoylquinoxaline-1,4-dioxide 
(2M3BenzoilQNX), 2-methyl-3-benzylquinoxaline-1,4-dioxide (2M3BQNX), 2-amino-3-
cyanoquinoxaline-1,4-dioxide (2A3CQNX), 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide 
(3M2QNXC), 2-hydroxyphenazine-N-dioxide (2HF), 3-amino-2-quinoxalinecarbonitrile-1,4-
dioxide (3A2QNXCN) and 3-methyl-N-(2-methylphenyl)quinoxalinecarboxamide-1,4-dioxide 
(3MN(2MF)QNXC).  
The first step was to design all the molecules in the Gabedit software. Gabedit allows 
drawing molecules by atom or by fragment, owning a database with more than 100 fragments 
available (linear molecules, ring molecules, polypeptides, polynucleic acids, among others). It 
is important to double check all the structures, to examine if all the bonds and atoms are in the 
right positions, since this step will constrain all the further results.  
After all compounds have been correctly drawn, the next step was to obtain the Z-matrix 
and consequently the input file for Gaussian software. Still in Gabedit software, we selected 
the Gaussian icon, to introduce all the desirable parameters. In here we had to choose the 
method, basis set and type of calculation. The method used was HF, the basis set was 6-31G** 
(as explained in Chapter III), and the type of calculation was the geometry optimization. For 
the calculation was choosed the geometry optimization and selected the Z-matrix box (can 
also be selected XYZ coordinates), to obtain the Z-matrix of each quinoxaline. After all 
paramethers selected we click in the NEXT button, obtaining a new window with Z-matrix of 
the molecule. In page 32 of this work is explained how to read the Z-matrix file. The geometry 
can be optimized by defining variables, but in this study the Z-matrix don’t have any variable 
defined. Then, clicking on the FINISH button, Gabedit software generates the input file, 
necessary for Gaussian. 
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The files are then introduced in Gaussian, and after processed, it will prepared a dat. file, 
which will allow us to calculate the single point energy. The single point energy will be 
introduced in Gabedit, to analyze various properties of the compounds and to understand their 
different reactivity. At this moment only two compounds reached the final stage of the 
Gaussian process, and the remaining quinoxaline files are running. In this work we present the 
single point energy of the quinoxaline-1,4-dioxide, present in the Chapter VI. The first line of 
the file indicates the number of processors used in the analysis; the second line indicates the 
memory extention necessary for the process; the third line indicates the name of the single 
point chk. file; the fourth and fifth line indicates all the specific instruction for the calculation 
(B3LYP and SCF); the sixth line is the name the user give to the file; the seventh give us the 
charge (in this case is 0, i.e., do not have positive or negative charge) and multiplicity (for this 
compound is 1, which means that there are no unpaired electrons); the next lines correspond to 
the Z-matrix, optimized with variables. 
The computational processes are cumbersome and require a certain amount of time. By 
restrainments imposed by the article 20
th
 of the 74/2006 law from Education and Science 
Ministry of the Portuguese government, which dictates the duration for the dissertation 
required time, it is not possible, at the present time, to describe all the results proposed in the 
objectives. 
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8.Conclusions 
The literature survey reveals that quinoxaline and their derivatives have a vast 
application, with a great potential, being an important class of biological active compounds. 
Quinoxaline and its derivatives showed a wide field of application in medicine due to its 
biological activities, that include antimicrobial, antitubercular, antiviral, antifungal, 
antiamoebic, antimalarial and leishmanial, antidiabetic, antiproliferative, anti-inflamatory, 
anticancer, antiglaucoma, antidepressant activities and also with AMPA-R antagonist activity. 
The biological activities referred are very encouraging for the investigators and pharmacists, 
leading to new treatments and therapeutic agents that will benefict humanity. Regarding 
quinoxaline derivatives potential in industry, they have shown great outcomes in metal 
corrosion inhibition, led to an increase in both sensitivity and selectivity in Cu
2+
 detection in 
colorimetric sensors, and showed to be excellent as host materials for use in phosphorescent 
OLEDs. These findings are very important for the industry field, decreasing costs (inhibition 
metal corrosion) and increasing efficiency (OLED).  
The experimental studies of the quinoxalines and its derivatives provide a valious 
information about their features, but it is crucial a deep understanding of the molecules. Thus, 
theoretical chemistry methods have been introduced as novel, effective and inexpensive ways 
to perform the primary characterization of the compounds. Computational chemistry is the 
natural sequence of the theoretical chemistry, which is used to represent molecular structures, 
simulating its behavior with classic and quantum physics equations. It is a well developed 
method to determine molecular properties, using one of the three quantum approaches: ab 
initio methods, semi-empiric methods and methods based on DFT. 
The softwares that were used to analyze quinoxalines are the Gabedit and Gaussian, 
computational chemistry softwares which allow determining a large number of compounds 
features such as the calculation of energies, geometries, vibrational frequencies, transition 
states, reaction pathways, excited states and a number of properties based in wave functions 
correlated and non-correlated. 
In the present work, the Gabedit proved indeed to be a useful method to design the 
compounds and extract the Z-Matrix, as well as the preliminary stage of writing the Gaussian 
dat. files. The computational data is being obtained, as the computer cluster runs the single-
point calculations and future perspectives of a insightful analysis are positive. 
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There is some enthusiastic hope that the present work will allow us to understand the 
particular microscopic features that may explain the differences in the quinoxalines reactivity 
and biological activity, as the computational calculations reach successful end and are then 
analyzed. 
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Abstract: 
Quinoxaline derivatives are an important class of heterocycles compounds, where N, S and O 
elements replace the carbon atoms in the ring. Quinoxaline molecular formula is C8H6N2, 
formed by two aromatic rings, benzene and pyrazine with a molecular weight of 130.1466400, 
and it appears as a white crystalline powder. It is rare in natural state, but their synthesis is 
easy to perform. Modifying its structure provides a wide variety of activities. They present a 
large number of biological activities such as antimicrobial, antitubercular, antiviral, antifungal, 
antiamoebic, antimalarial and leishmanial, antidiabetic, antiproliferative, anti-inflamatory, 
anticancer, antiglaucoma, antidepressant and presenting AMPA antagonism. They are also 
important in industrial field due to its power in metal corrosion inhibition, its use in Cu
2+
 
detection in colorimetric sensors, and phosphorescent organic light-emiting diodes (OLEDs). 
The present review attempt to review quinoxaline derivatives characteristics, and its 
importance in both biological and industrial field. 
Keywords: Quinoxaline, biological activity, industry. 
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Introduction: 
Quinoxaline derivatives are an important class of heterocycles compounds, in which N, 
S and O elements replace one or more carbons atoms of the ring[1], and the approved number 
for the quinoxaline ring system is shown in Figure 1, where 2 and 3 are designated α-
positions[2]. They are important in industry due to their power to inhibit the metal corrosion[3-
5], in the preparation of the porphyrins since their structure is similar to the chromophores in 
the natural system, and are also usefull in the electroluminescent materials[6-8]. In 
pharmacological industry they are considered promising molecules since they show wide 
biological properties[1, 9-12] such as antibacterial, antifungal, anticancer, antitubercular, 
antileishmanial, antimalarial, antidepressant, antimycobacterial and anticandida, and 
neurological activities, among others. All this activities are possible due to the quinoxaline 
structure since its nucleus, in numerous cases, acts as a precursor to assembly a large number 
of quinoxaline derivatives, which consequently, provide a large number of new compounds for 
diverse applications[1]. 
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Figure 1 should come about here 
 
Quinoxaline is formed by two aromatic rings, benzene and pyrazine. For this reason is 
also called benzopyrazine, and is described as a bioisoster of quinoline, naphatelene and 
benzothiophene[13]. The atoms S and N play an important role in the ring since they stabilize 
ion radical species and extended π-conjugation facilitate in decreasing columbic repulsion. 
Molecular weight of the quinoxaline is 130.1466400, with a molecular formula of C8H6N2, 
and it is a white crystalline powder[1].  
Chemically, quinoxaline is a low melting solid, purified by destilation, and a fraction of 
b.p. 108º-111º/12mm has a m.p. 29-30ºC[2, 13]. Quinoxalines are soluble in water, and 
produces monoquaternary salts when treated with quaternizing agents, like methyl sulfate and 
methyl p-toluenesulfate. The quaternary salts of 2-alkylquinoxalines are unstable and can be 
converted into complex colored products when under oxidation[2]. It is weakly basic with a 
pKa of 0,60 in water at 20ºC, and nitration occurs only under forcing conditions (Conc. HNO3, 
Oleum, 90ºC), resulting the formation of two compounds: 5-nitroquinoxaline (1,5%) and 5,7-
dinitro-quinoxaline (24%) [13]. Its second pKa is -5,52, meaning that quinoxaline is 
significantly diprotonated only in a strongly acidic medium[2]. 
Quinoxaline has a dipole moment of 0,51 D in benzene ring, and their first and second 
ionization potentials, measured by photon electron spectroscopy, are 8,99 and 10,72 eV, 
respectively[2]. However it is not known certainly from which orbital the first electron is lost, 
since highest-occupied π-orbital and non-bonding orbitals are very close in energy. The heat of 
atomization was calculated to be 79,739 eV by a self-consistent field molecular orbital 
treatment[2]. Molecular orbital calculations of the π-electron density were made, and shown 
that the highest electron density at the ring carbon is at positions 5 and 8, followed by 
positions 6 and 7, and the lowest at 2 and 3 positions[2]. 
 
Table 1 should come about here 
 
Most of quinoxaline compounds are rare in natural state, being of synthetic origin. The 
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method used to synthesized quinoxalines is to condense o-disubstituted benzene with a two 
carbon synthon. Therefore, the condensation of o-phenylenediamine with α-dicarbonyl 
compounds result in quinoxaline formation (Figure 2)[2]. 
  
Figure 2 should come about here 
 
Quinoxaline and their derivatives could be converted in both mono and di-N-oxides by 
oxidation with peracids[2]. 
Biological Activity 
The study of quinoxaline, and its derivatives, has become a subject of interest in recent 
years, due to their wide variety in biological activity and also their therapeutic applications, 
such as antimicrobial agents since some antibiotics have quinoxaline compound in their 
structure (echinomycin), and some recognized drugs like Brimonidins which alleviates 
glaucoma symptoms[1]. Although rare in nature, synthesized quinoxaline and derivatives are 
included in various antibiotics such as echinomycin, levomycin and actinomycin, which are 
known to inhibit the growth of Gram-positive bacteria and also active against transplant 
tumors[13, 14]. 
The vast scope of synthesized quinoxaline and derivatives potentials is well referenced 
and published in a wide range of scientific journals. We analyze in detail, transversally and in 
context the relevant scientific data pertaining great quinoxaline and potentials derivatives in 
literature. 
 
Antimicrobial Activity 
The antimicrobial-resistance is a serious threat to global public health, result of the 
widely disseminated and careless use of antimicrobials, and demands a continuous effort in 
order to seek for better antimicrobial agents effective against resistant pathogenic 
microorganisms[13, 15-17]. There are a wide range of quinoxaline derivatives with 
antimicrobial activity documented. 
A new series of 8-chloro-1,4-substituted(1,2,4)triazolo(4,3a) quinoxaline derivatives 
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(Figure 3) (Table 2) was synthesized and screened for antimicrobial and antioxidant 
activities[18]. The antibacterial activity was screened against Gram-positive Staphylococcus 
aureus and Bacillus subtilis, and Gram-negative Proteus vulgaris and Klebsiella pneumoniae, 
using chloramphenicol as reference drugs[16]  
 
Figure 3 should come about here 
 
Ammar et al[19], have synthesized thieno(2,3-d)pyrimidines and pyrrolo(3,4-
b)quinoxalines which antibacterial activity were tested against Staphyllococcus aureus and 
Escherichia coli.  
 Also, an in vitro fluorescence polarization assay demonstrated that a library of 
quinoxaline derivatives, prepared to target non-structural protein 1 of influenza A (NS1A), 
disrupted the dsRNA-NS1A interaction to varying extents, which lead to the development of 
anti-influenza drugs[38]. 
 
Figure 4 should come about here 
 
 In such study, researchers have prepared a library based on 2,3-difuryl-4-
quinoxaline(R)metilcarboxamide derivatives (Figure 4), with 2-furyl groups at position 2 and 
3, and phenyl group in position 6 through an amide linker. Among all the compounds in the 
library, those listed in Table 2 have shown the highest effectiveness. These compounds do not 
inhibit NS1A-dsRNA interactions by interfering with dsRNA but by the binding to NS1A 
dsRNA-binding domain itself. Also the compound 2 was able to inhibit influenza A virus 
growth[38]. 
 
Antitubercular Activity 
 Tuberculosis (TB) is a contagious disease, caused by the infection of Mycobacterium 
tuberculosis, which have a high rate of mortality in the world. About 3 million people die 
every year from TB, and 8 million new cases estimated each year, which 95% of them occur in 
developing countries[20-22]. 
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 The therapy used in these days to fight TB consists in the administration of one of three 
drugs (isoniazid, rifampin or pyrazinamide) for 2 months, followed by 4 months of follow-up 
therapy with isoniazid and rifampin. However, the arising of multidrug resistant (MDR) TB it 
is required the development of new therapeutic agents, with a unique mechanism of action, 
able to treat MDR forms of the disease. 
 Several studies has been described, concerning synthesis and biological activity of a 
large amount of quinoxalines and 1,4-di-N-oxide quinoxaline derivatives, where compounds 
such as 7-chloro-3-(p-substituted)phenylaminoquinoxaline-2-carbonitrile 1,4-di-N-oxide, 6,7-
dichloro-2-ethoxycarbonyl-3-methylquinoxaline 1,4-di-N-oxide and 3-acetamide-6,7-
dichloroquinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives have been shown to inhibit M. 
tuberculosis to a rate of 99 to 100%[16, 23]. However, it is observed that the lack of the two 
N-oxide groups lead to the loss of the antimycobacterial activity [23-25]. 
Some novel condensed bridgehead nitrogen heterocycles of quinoxalines has been 
synthesized and showed activity against M. tuberculosis H37Rv species [13, 16, 26]. The 
compounds 3-methyl-2-phenylthioquinoxaline 1,4-dioxides generally showed a good activity 
against M. tuberculosis in the preliminary in vitro evaluation and exhibited MIC between 0.39 
and 0.78µg mL
−1
(rifampicin MIC=0.25µg mL
−1
)[9].  
It was also reported the activity of 3-methyl-9-substituted-6-oxo-6,9-dihydro-3H-(1,2,3)-
triazolo(4,5-h)quinolone-carboxylic acids and their esters of as a new class of anti-infective 
agents against MDR M. tuberculosis, with no cytotoxicity reported[28]. 
 
Antiviral Activity 
Viruses such as Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) belong to the 
Herpesviridae family, are double-stranded DNA[30], and share high homology in genome 
structure and DNA sequence. These viruses can cause various illness states from 
asymptomatic infection to fulminant disseminated diseases, including labials herpes, keratitis, 
genital herpes, and encephalitis[31, 32]. 
There are a wide number of drugs for treatment of Herpes simplex virus (HSV) 
infections like acyclovir, ganciclovir, penciclovir, valaciclovir (converted to acyclovir) and 
famciclovir (converted to penciclovir)[30, 33], being acyclovir the most common drug used. 
However, there are drug-resistant strains of HSV emerging and increasing[30, 34], leading to 
COMPUTATIONAL ANALYSIS OF QUINOXALINES N-N-DIOXIDE AND ITS DERIVATIVES FEATURES 
79 
the search of new antiviral drugs. 
Quinoxalines have a variable antiviral activity, suggesting that their activity depends on 
specific substitution patterns. Novel series of al 6H-indol-(2,3-b)quinoxalines were 
synthesized and evaluated for antiherpes virus activity and the compound 2,3-
dimethyl(dimethylaminoethyl)5H-indolo-(2,3-b)quinoxaline had the major antiviral activity. 
This specific compound was tested for its antiviral affect and action mechanism, showing the 
capacity to inhibit replication of herpes simplex virus type 1, cytomegalovirus, and varicella-
zoster virus in tissue culture, in concentrations of 1 to 5µM, depending on the virus amount 
and cell type used in the assay. Also the compound 2,3-dimethyl-6-(dimethylaminoethyl)-6H-
indolo-[2,3-b]quinoxaline (Figure 5) have showed high activity against herpes virus, and 
derivatives with 6-(2-dimethylaminoethyl) side chain, due to their DNA binding properties, 
showed an improved biological activity[1].  
 
Figure 5 should come about here 
 
There is also reference to IndQloquinoxalines with capacity to inactivate virions in high 
concentrations (around 300µM), and decrease the synthesis of viral DNA and protein at lower 
concentrations (around 3µM)[16]. 
 Concerning human immunodeficiency virus type 1 (HIV-1), which is the agent 
causative of acquired immunodeficiency syndrome (AIDS)[35-37], there are a wide number of 
clinical drugs used to fight the disease, such as non-nucleoside reverse transcriptase (RT) 
inhibitors, which interact with a specific allosteric non-substrate binding site on HIV-1 
RT[13]. Compound 6-chloro-3,3-dimethyl-4(isopropenyloxycarbonyl)-3,4-dihydroquinoxalin-
2(1H)-thione (Figure 6) was synthesized and evaluated for enzyme activity, and was found to 
be a very potent inhibitor for both HIV-1 RT activity and HIV-1 replication in tissue cultures. 
Although, like some other non-nucleoside RT inhibitors, this compound was not effective 
against HIV-2 RT[16].  
 
Figure 6 should come about here 
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Antifungal Activity 
Prevalence of fungal diseases has increased significantly in the past 50 years. Fungal 
diseases manifest themselves differently, including mycoses in the skin, hair, nails, but also as 
systemic mycoses, being the last one an issue of great medical concern due to the increase in 
the immunocompromised patient population[39]. 
One of the most common fungal infections is candidiasis, caused by Candida albicans, a 
diploid fungus that grows both as yeast and filamentous cells[40, 41]. This fungus can also 
develop resistance to antimycotic drugs that already exist in the market[42], being important a 
constant search for new drugs and treatments. 
Thieno(2,3-d)pyrimidines and pyrrolo(3,4-b)quinoxalines were synthesized, have 
antifungal activity, and were tested against C. albicans[13, 19]. 
Researchers also reported some 2-sulphonylquinoxalines and 3-
[(alkylthio)methyl]quinoxaline 1-oxide derivatives as compounds with high antifungal 
activity[9], and also pyrazoloquinoxalines which were observed to be active against fungal 
infections[1].  
 
Antiamoebic Activity 
 Entamoeba histolytica is a protozoan responsible for the amoebiasis infection[43, 44], 
causing amoebic colitis, brain and liver abscess, being the second leading cause of death 
worldwide. The traditional treatment used is based in antiamoebic compounds such as 
nitroimidazoles, but not always effective, raising the possibility of drug resistance, leading to 
the search of new compounds able to fight the infection successfully[45].   
Some 1-(thiazole[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazolines derivatives produced 
(Figure 7), were found to be a potent inhibitor of HM1:IMSS strain of E. histolytica, where the 
presence of 3-bromo or 3-chloro substituents on the phenyl ring and 4-methyl group on the 
pyrazoline ring affected antiamoebic activity to a great extent[45].  
 
Figure 7 should come about here 
 
In such study metronidazole was used as the reference drug and had a 50% inhibitory 
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concentration (IC50 1.69–1.82 µM), and compound 6 (Table2) showed great effectiveness, 
being the most active [45]. 
 
Antileishmanial and Antimalarial Activity 
 Leishmaniasis is a parasitic disease cause by protozoan of the genus Leishmania in 
tropical and subtropical areas of the World, and despite all efforts to fight this disease about 1-
2 million new cases are registered every year[16, 46]. Most of the drugs available against 
leishmaniasis are expensive and require a long treatment and are becoming more and more 
ineffective[11]. 
Malaria is also a tropical parasitic disease, cause by Plasmodium falciparum, leading to 
over a million deaths annually, and rising, probably due to a resistance increasing, requiring 
the development of cheaper and more effective drugs[11, 47-49]. 
Carlos Barea, et al[11], synthesized 14 new 3-amino-1,4-di-N-oxide quinoxaline-2-
carbonitrile derivatives. These compounds were evaluated for their in vitro antimalarial and 
antileishmanial activity against P. falciparum (Colombian FCR-3 strain) and Leishmania 
amazonensis (strain MHOM/BR/76/LTB-012A). The study showed that compounds with one 
halogenous group in position 6 and 7 provide an efficient approach for further development of 
antimalarial and antileishmanial agent. 
 
Antidiabetic Activity 
Diabetes Mellitus is a disease caused by the dysfunction of glucose homeostasis, in 
which glucose levels appear abnormal with tendency to hyperglycemia. Diabetes type 1 is 
insulin-dependent and requires a daily subcutaneous injection of insulin, while diabetes type 2 
is non-insulin-dependent and can be treated with several drugs such as sulfonylureas, 
nateglinide, biguanides, etc. However these treatments have limited efficacy and tolerability, 
and could cause severe side effects[50]. In this regard, were prepared new transition metal 
complexes of quinoxaline-thiosemicarbazone ligands L
1
H2 and L
2
H2 (Figure 8). The ligands 
were explored with copper and zinc complexes in diabetes induced Wister rats. The 
compounds [ZnL
1
(H2O)] and L
2
H2 have showed prominent reduction in blood glucose level 
and the complexes [CuL
1
(H2O)], [ZnL
1
(H2O)] and [CuL
2
(H2O)] have exhibited good activity 
in oral glucose tolerance test (OGTT) and showed low toxicity[12].  
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Figure 8 should come about here 
 
Also (N-arylcarbamoyl and N-aryl thiocarbamoyl)hydrazinequinoxalin-2(1H) (Figure 9) 
have been reported as mild hypoglycaemic agents[1]. 
 
Figure 9 should come about here 
 
Anti-inflammatory Activity 
 Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in therapeutics, 
generally for the treatment of the pain and inflammation. Nevertheless its long-term usage can 
lead to significant side effects like gastrointestinal lesions, bleeding, and nephrotoxicity. Due 
to those reasons mentioned it is important the discovery of new safer anti-inflammatory drugs 
[51-53]. 
Quinoxaline 1,4-di-N-oxide derivatives such as 4-(7-fluoro-3-methyl-quinoxalin-2-yl)-6-
(3,4,5-trimethoxy-phenyl)-pyrimidin-2-ylamine and 2,6,7-trimethyl-3-[5-(3,4,5-trimethoxy-
phenyl)-4,5-dihydro-1H-pyrazol-3-yl]-quinoxaline, showed an in vivo anti-inflammatory 
effect, higher than one reference drug, IMA (indomethacin), and in vitro decreasing values of 
LOX (lipoxygenase). LOX is an enzyme essential to arachidonic acid (AA) metabolism, which 
leads to the formation of leukotrienes, a type of pro-inflammatory mediator involved in 
processes like fever, asthma and cardiovascular disease[54, 55]. It was demonstrated that the 
incorporation of pyrimidine, thiazolopyrimidine, pyrazolopyridine, pyridopyridine, p-
chlorophenyl, p-methoxyphenyl or pyridine nucleus to quinoxaline moiety cause significant 
anti-inflammatory activity, and also analgesic[51]. 
 
Anticancer Activity 
Quinoxaline nucleuses exhibit potential anticancer activity, which makes them an 
important basis for the anticancer drugs[16]. A new series of 2-alkylcarbonyl and 2-benzoyl-3- 
trifluromethylquinoxaline-1,4-di-N-oxide derivatives was synthesized and evaluated for in 
vitro antitumor activity against a 3-cell line panel (MCF7 (breast), NCIH 460 (lung) and SF-
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268 (CNS)), and then evaluated in full panel of 60 human tumor cell lines, derived from nine 
cancer cell types. It was showed that, in general, anticancer activity depends on the 
substituents in the carbonyl group, increasing the activity in the order: ethyl<isopropyl<tert-
butyl<phenyl-ones. Among these the compounds (Figure 10) 2-Isobutyryl-3-
trifluoromethylquinoxaline 1,4-di-N-oxide (Compound 1), 2-benzoyl-6,7-dichloro-3-
trifluoromethylquinoxaline 1,4-di-N-oxide (Compound 2), their diﬂuorinated analogs (6,7-
diﬂuoro-2-isobutyryl-3-triﬂuoromethylquinoxaline 1,4-di-N-oxide and 2-benzoyl-6,7-diﬂuoro-
3-triﬂuoromethylquinoxaline 1,4-di-N-oxide)  (Compound 3 and 4), and 2-(2,2-
dimethylpropanoyl)-3-trifluoromethylquinoxaline 1,4-di-N-oxide (Compound 5) were the 
most active, with higher anticancer activity with mean GI50 (Growth Inhibition) values of 1.02, 
0.42, 0.52, 0.15, and 0.49 µM, respectively (Table2)[10, 16]. 
 
Figure 10 should come about here 
 
Antiglaucoma Activity 
 Glaucoma is the designation to refer the diseases that affect the optic nerve, involving 
the loss of retinal ganglion cells in a characteristic pattern of optic neuropathy, and 
excavations of the nerve head[58-60]. Almost 67 million people worldwide are affected by 
glaucoma, remaining the leading cause of irreversible blindness, responsible for 14% of 
blindness after cataract and trachoma[61, 62]. 
Alphagan
®
 (Brimonidin) is a relatively selective alpha-2 adrenergic receptor agonist, 
and its composition consists in (5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxaline 
(Figure 11). This drug works as an antiglaucoma agent, due to its power to reduce the 
intraocular pressure, alleviating the symptoms of glaucoma[1, 16]. 
 
Figure 11 should come about here 
 
Antiproliferative Activity 
After artery injury, abnormal proliferation and migration of vascular smooth cells 
(SMCs) into the intimal layer of the arterial wall occurs, proliferating and synthesizing 
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extracellular matrix components, playing an important role in coronary artery atherosclerosis 
and restenosis after an angioplasty[64, 65].  
A series of 6-arylamino-2,3-bis(pyridin-2-yl)-7-choloroquinoxaline-5,8 diones (Figure 
12) were synthesized and screened for their inhibitory activity on rat aortic smooth muscle cell  
(RAoSMC) proliferation. IC50 (Inhibition Concentration) values were determined and 
compared to the positive control mycophenolic acid
 
(MPA) (Table 2), and most of the 
compounds showed good activity, and the quinoxaline-5,8-diones  was found as an potent 
antiproliferative agent[1, 16, 66]. 
 
Figure 12 should come about here 
 
Antidepressant Activity 
5-Hydroxytryptamine (5HT), commonly known as serotonin, is a neurotransmitter 
involved in a great number of physiological and patho-physiological processes, acting 
through the receptor subtypes, which are 5-HT1-7. Almost all of the receptors subtypes belong 
to the family of G-protein coupled receptor (GPCR), but the specific receptor subtype 5HT3 
is a ligand gated ion channel[67, 68]. The antagonists to this receptor lead to a various 
responses, such an anti-emetic action in cancer chemo-/radio-therapy induced nausea and 
vomiting, anti-depressant, anxiolytic, anti-phsycotic and anti-inflammator. Although, the 
drugs available to depression conditions have a delayed onset of action, which emphasizes 
the demand of new antidepressant drugs, with a safer and faster action[67, 68]. 
New series of structurally novel 3-substituted-2-carboxamides quinoxaline were 
designed as 5-HT3 receptor antagonists using ligand-based approach. All the compounds 
synthesized exhibited 5-HT3 receptor antagonism, and some of them showed antagonism 
greater than the standard drug, ondansetron, like (3-ethoxyquinoxalin-2-yl)(4-
methylpiperazin-1-yl)methanone and N-(2-(1H-indol-3-yl)ethyl)-3-ethoxyquinoxaline-2-
carboxamide[68].  The compound N-{3-[(4-methylpiperazin-1-yl)methyl]-4-
hydroxyphenyl}-3-methoxyquinoxalin -2-carboxamide showed most favorable 5-HT3 
receptor antagonism[16]. 
Also 3-benzyl-2-substituted quinoxalines were synthesized as novel monoamine 
oxidase A (MAO-A) inhibitors. These MAO inhibitors are very useful for the treatment of 
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several neurological diseases, like Parkinson and depression. MAO-A inhibitors are used as 
antidepressant and antianxiety drugs. In this study, the final compounds were evaluated for 
their MAO-A inhibitory activity in vitro, using serotonin as substrate[13]. 
 
Anti excitotoxicity activity of glutamate 
A major excitatory neurotransmitter in the central nervous system in mammalian species 
is the glutamic acid, an excitatory amino acid (EAA). Although, if a overstimulation of the 
postsynaptic glutamate receptors occurs, due to a high release of EAA, could result in neuronal 
death, and consequently induce neurodegenerative disorders such as Alzheimer and 
Huntington’s disease[69-73]. AMPA-R (α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic 
acid receptor) antagonists have showed to have no side effects such as schizophrenia and 
protective activity in neural death, and many quinoxalinedione derivatives with competitive 
AMPA-R antagonistic activity have been synthesized and tested against the EAA receptor[74]. 
The compound 7-[4-[N-[4-carboxyphenyl]carbamoyloxy]methyl]imidazolyl]-3,4-
dihydro-6-nitro-3-oxo-quinoxaline-2-carboxylic acid (GRA-293) was identified as a novel 
AMPA-R antagonist due to its high potency and good selectivity in vitro, and its potent 
neuroprotective effects in an animal model in vivo, than the known quinoxalinedione 
compounds used. These effects are due to a novel substituent, namely substituted benzene ring 
with urethane linkage to imidazole, in C-7 position, which leads to a potent AMPA-R affinity 
and contributes to therapeutic efficacy in animal models. This compound, with such 
charactereristics, meets the criteria, in an injectable formulation, for use in the treatment of 
acute cerebral ischemia[74]. 
Industrial applications 
Corrosion Inhibition 
 The use of acid solution is very common in industry, and has important fields of 
application like acid pickling, industrial acid cleaning, acid descaling and oil well acidizing. 
However, the continuous use of acid solutions can lead to the metal corrosion, leading to 
enormous economic losses. Thence the importance of having inhibitors to minimize the metal 
dissolution and acid consumption, instruments malfunction and contamination[5, 75].  
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 The most effective inhibitors used in industry to minimize these losses are organic 
compounds. Their inhibitory effect is reinforced by the presence of heteroatoms such as 
sulphur, nitrogen and oxygen, which will facilitate its adsorption on the mild steel surface 
following the sequence S>N>O[3, 75]. 
Other studies revels that the adsorption in mild steel surface also depends on the 
physicochemical properties of the inhibitor group, planarity of the system, presence of 
multiple adsorption active centers with lone pair and/or π orbitals, molecular size and 
electronic density at the donor atom. On this basis, the choice of effective inhibitors is done 
taking in consideration their structure, their mechanism of action and their electron donating 
ability[3]. Many N-heterocyclic organic compounds are good corrosion inhibitors, but some of 
them are highly toxic to both human beings and environment, leading to a continue search for 
an eco-friendly and harmless N-heterocyclic compounds as inhibitors[76].  
Quinoxaline derivatives are N-heterocyclic aromatic compounds that have been proved 
to be excellent corrosion inhibitors for mild steel in acidic media, easy to synthesized and 
ready available[77]. 
2,3-quinoxalinedione (QD) (Figure 13) was used to study their corrosion inhibition 
properties for mild steel in 1M HCl, due to the presence of heteroatoms N and O, and π-
electrons. It was shown that QD can act as a good corrosion inhibitor for mild steel in 1M HCl, 
with an inhibition efficiency of 88% at 10
-3
M (measured through weight loss)[75]. 
Figure 13 should come about here 
 
Indeno-1-one [2,3-b] quinoxaline (INQUI) (Figure 14), was synthesized and tested for 
inhibition corrosion of mild steel in 0,5M H2SO4, and showed about 81% of inhibition 
efficiency at 10
-6
M. This efficiency increases with INQUI concentration but decreases with 
immersion time[76]. 
 
Figure 14 should come about here 
 
Also acenaphtho [1,2-b] quinoxaline (AQ) (Figure 15) was tested as a corrosion 
inhibitor for mild steel in 0,5 MH2SO4. AQ acts as an effective inhibitor for mild steel in 
acidic, with 80% of inhibition efficiency at 10
-6
M (measured through weight loss)[77]. 
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Figure 15 should come about here 
 
Quinoxaline derivatives namely 3-methyl-2-phenyl quinoxaline (MPQ), 2,3-diphenyl 
quinoxaline (PPQ), 3-methyl-2(2-hydroxyphenyl)quinoxaline (MHPQ), 3-phenyl-2(2-
hydroxyphenyl)quinoxaline (PHPQ) and 3-methyl-2(3-methoxy,4-hydroxyphenyl)quinoxaline 
(MMtHPQ) have been shown through experimental studies to have high corrosion inhibition 
efficiencies for copper in nitric acid, with the order of inhibition efficiency being MMtHPQ > 
PPQ > MPQ > PHPQ > MHPQ[5]. 
 
Cu
2+
 detection - Colorimetric Sensor 
 Cu
2+ 
is a transition-metal ion, crucial in the life processes, since it has an important role 
as a catalytic cofactor for a variety of metallo-enzymes such as superoxide dismutase, 
cytochrome c oxidase, lysyl oxidase and tyrosinase, etc. However when overloading, exhibit 
toxicity and could cause a variety of neurological diseases. Besides, it is also important in 
pollution matters, since the formulation of copper-containing pesticides uses various forms of 
copper, which in the end dissociates into Cu
2+
[78, 79].   
 There are well developed technologies to detect Cu
2+
 such as inductively  coupled  
plasma  detectors, surface-plasmon  resonance  detectors,  ﬂuorescence  anisotropy assays,  
quantum-dot-based  assays,  electrochemical  sensors  and fluorescence sensors. These are 
technologies with high sensitive and speciﬁcity in the Cu2+ detection, but also very expensive, 
due to the need of sophisticated instruments and highly trained operators. On the other hand, it 
is possible to use a naked-eye detection method, which gives a more fast response without 
involving any costly instrument. Although this method allows a good qualitative approach it 
presents a low sensitivity[79]. 
A colorimetric receptor  ninhydrin–quinoxaline  based  was  designed,  synthesized  and  
characterized, and  exhibited  high  sensitivity  and  selectivity  for  Cu
2+
 in  aqueous  medium  
over  a  wide  variation  of  cations  such  as  Na
+
,  Mg
2+
,  Al
3+
,  Co
2+
,  Fe
3+
,  Ni
2+
,  Zn
2+
,  Cd
2+
,  
Hg
2+
 and  Pb
2+
. In this study Cu
2+
 was added  to  the  receptor  solution  giving a  clear  colour  
change  from  olive  green  to  pink.  The detection  limit was  found  to  be  3,43x10
−7
 M  
which  is  one of  the  lowest for  the  Cu
2+
 in  an  aqueous  solution  by  any  naked-eye  
receptor[79].  
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OLED - organic light-emitting diode 
 Phosphorescent OLEDs are well known due to its high efficiency (possibility of 100% 
internal quantum efficiency)[80]. This property is driving the investment on research, leading 
to the synthesis of new compounds and materials as hosts, charge transporting materials and 
emitters. The high efficiency is due to PHOLED capacity to harvest both singlet and triplet 
excitons for light emission[81, 82]. However, triplet emitters tend to decrease the efficiency 
because of the concentration triplet-triplet annihilation during device operation despite of 
owing long emissive lifetimes. The solution is to develop new bipolar host materials, which 
will contribute to the balanced transport of carriers and help to increase the probability of 
carrier recombination, and will grant better device stability due to its amorphous nature[82].  
New series of carbazole/quinoxaline hybrids with 1,3,5-benzene core have been 
synthesized, and showed excellent thermal and morphological stabilities, due to their twisted 
geometry. These compounds, bipolar along with high thermal stability and favorable 
electrochemical properties, are promising for their use as host materials in red and green 
phosphorescent based OLEDs[82]. 
Conclusions 
The literature survey reveals that quinoxaline and their derivatives have a wide 
application, with a great potential, being an important class of biological active compounds. 
This review tries to embrace quinoxalines features such its biological activities and industrial 
value. Quinoxaline and its derivatives showed a wide field of application in medicine due to 
its biological activities, that include antimicrobial, antitubercular, antiviral, antifungal, 
antiamoebic, antimalarial and leishmanial, antidiabetic, antiproliferative, anti-inflamatory, 
anticancer, antiglaucoma, antidepressant activities and also with AMPA receptor antagonist 
activity. The biological activities referred are very encouraging for the investigators and 
pharmacists, leading to new treatments and therapeutic agents that will benefict humanity. 
Regarding quinoxaline derivatives potential in industry, they have shown great outcomes in 
metal corrosion inhibition, led to an increase in both sensitivity and selectivity in Cu
2+
 
detection in colorimetric sensors, and showed to be excellent as host materials for use in 
phosphorescent OLEDs. These findings are very important for the industry field, decreasing 
costs (inhibition metal corrosion) and increasing efficiency (OLED). We hope, with this 
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review along with the easy process of quinoxaline derivatives synthesis, to lead to further 
development of the quinoxaline nucleus, allowing the research for new compounds, its 
features and potentials. 
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 Anexes: 
 
Figure 1: Quinoxaline compound: a) Lewis structure; b) 3D structure. 
 
Figure 2: Quinoxaline synthesis. 
 
Figure 3: 8-chloro-1,4-substituted(1,2,4)triazolo(4,3a) quinoxaline derivatives core: a) Lewis structure; b) 3D structure. 
a) b) 
a) b) 
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Figure 4: 2,3-difuryl-4-quinoxaline (R) metilcarboxamide derivatives compound: a) Lewis structure; b) 3D structure. 
 
Figure 5: 2,3-dimethyl-6-(dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline compound: a) Lewis structure; b) 3D structure. 
 
Figure 6: 6-chloro-3,3-dimethyl-4(isopropenyloxycarbonyl)-3,4-dihydroquinoxalin-2(1H)-thione compound: a) Lewis 
structure; b) 3D structure. 
 
a) b) 
a) b) 
a) b) 
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Figure 7: 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazolines core: a) Lewis structure; b) 3D structure. 
 
Figure 8: Ligands L1H2 and L
2H2. For L
1H2, R=CH3 and for L
2H2, R=C6H5: a) Lewis structure; b) 3D structure. 
 
Figure 9: (N-arylcarbamoyl and N- aryl thiocarbamoyl) hydrazinequinoxalin – 2 (1H) compounds: a) Lewis structure; b) 3D 
structure. 
 
a) b) 
a) b) 
a) b) 
a) 
b) 
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Compound 1: 2-Isobutyryl-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 2: 2-benzoyl-6,7-dichloro-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 3: 6,7-diﬂuoro-2-isobutyryl-3-triﬂuoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 4: 2-benzoyl-6,7-diﬂuoro-3-triﬂuoromethylquinoxaline 1,4-di-N-oxide. 
 
Compound 5: 2-(2,2-dimethylpropanoyl)-3-trifluoromethylquinoxaline 1,4-di-N-oxide. 
Figure 10: Compounds 1 to 5: a) Lewis structure; b) 3D structure. 
a) b) 
a) b) 
a) b) 
a) b) 
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Figure 11: Alphagan chemical structure: a) Lewis structure; b) 3D structure. 
 
Figure 12: 6-arylamino-2,3-bis(pyridin-2-yl)-7-choloroquinoxaline-5,8 diones compounds: a) Lewis structure; b) 3D 
structure. 
 
Figure 13: 2,3-quinoxalinedione (QD): a) Lewis structure; b) 3D structure. 
 
Figure 14: Indeno-1-one [2,3-b] quinoxaline (INQUI) compound: a) Lewis structure; b) 3D structure. 
a) b) 
a) b) 
a) b) 
a) b) 
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Figure 15: Acenaphtho [1,2-b] quinoxaline (AQ) compound: a) Lewis structure; b) 3D structure. 
 
Quinoxaline Properties 
Formula C8H6N2 
Molecular Weight 130.1466400 
Acidity (pKa) 0,56 
Second pKa -5,52 
Melting Temperature 29-30ºC 
Natural State 
White crystaline 
powder 
Dipole Moment 0,51 D 
Ionization (1
st
/2
nd
) 8,99/10,72 eV 
Heat of atomization 70,739eV 
Table 1: Quinoxaline properties
a) b) 
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Main  Compound Compound R R’ R’’ 
% 
Binding 
at 50µM 
% 
Intercalation 
at 50 µM 
IC50µM IG50µM Reference 
8-chloro-1,4-
substituted(1,2,4)triazolo(4,3a) 
quinoxaline derivatives 
1 
 
-Cl - - - - - 
[16] 
2 
 
-SCH2COOH - - - - - 
3 
 
-OMe - - - - - 
4 
 
-SCH2COOH - - - - - 
5 
 
-Cl - - - - - 
6 
  
- - - - - 
7 
  
- - - - - 
8 -C3H7 
 
- - - - - 
9 
 
-SCH2COOH - - - - - 
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10 
 
 
- - - - - 
2,3-difuryl-4-quinoxaline (R) 
metilcarboxamide derivatives 
1 3-OMe-Ph- - - 74,0 4,5 6,2 - 
[38] 
2 2-Furyl- - - 79,5 5,9 3,5 - 
1-(thiazolo[4,5-b]cquinoxaline-2-
yl)-3-phenyl-2-pyrazolines 
derivatives 
1 H H - - - 6,76 - 
[45] 
2 Br H - - - 4,98 - 
3 Cl H - - - 1,09 - 
4 H CH3 - - - 2,34 - 
5 Br CH3 - - - 1,45 - 
6 Cl CH3 - - - 0,72 - 
Metronidazole - - - - - 1,69 - 
2-alkylcarbonyl and 2-benzoyl-3- 
trifluromethylquinoxaline-1,4-di-
N-oxide derivatives 
1 H H - - - - 1,02 
[10] 
2 Cl Cl - - - - 0,42 
3 F F - - - - 0,52 
4 F F - - - - 0,15 
5 H H - - - - 0,49 
6-arylamino-2,3-bis(pyridin-2-yl)-
7-chloro-quinoxaline 5,8-diones 
1 H Cl H - - 1,5 - 
[66] 
2 H OH H - - 5,5 - 
3 H F H - - 1,0 - 
4 H CF3 H - - 1,1 - 
5 H OCF3 H - - 1,0 - 
6 H OCH3 H - - 3,5 - 
7 H H H - - 3,1 - 
8 Cl Cl H - - 1,0 - 
9 F F F - - 1,2 - 
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10 - - - - - >100 - 
MPA - - - - - 1,0 - 
Table 2: Published experimental data (percentage of Binding, Intercalation, IC50 and IG50) of quinoxaline derivatives and their substituents. 
1. Asif Husain, D.M., Recent advances in pharmacological activities of quinoxaline derivates. Journal of pharmacy research, 2011. 4(3): p. 924-929. 
2. Lei You, E.J.C., John Leavitt, Li-Chung Ma, Gaetano Montelione, Eric Anslyn, Robert Krug, Andrew Ellington, Jon D. Robertus, Synthesis and evaluation of 
quinoxaline derivatives as potential influenza NS1A protein inhibitors. Bioorg. Med. Chem. Lett., 2011. 21: p. 4. 
3. Mohammad Abid, A.A., Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives. Bioorg. 
Med. Chem. Lett., 2006. 16: p. 4. 
4. Belén Zarranz, A.J., Ignacio Aldana, Antonio Monge, Synthesis and anticancer activity evaluationnof new 2-alkylcarbonyl and 2-benxoyl-3-trifluoromethyl-
quinoxaline 1,4-do-N-oxide derivatives. Bioorganic & Medicinal Chemistry, 2004. 12: p. 10. 
5. H Chung, O.J., M J Chae, S Hong, K Chung, S K Lee, C Ryu, Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth cell 
proliferation. Bioorg. Med. Chem. Lett., 2005. 15: p. 5. 
